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Introduction
The world has never  seen a comparable  complex  public  health  hazard as that 
which  it  is  currently  experiencing  in  dealing  with  the  effects  of  Human 
immunodeficiency virus infection (HIV) /Acquired immunodeficiency syndrome (AIDS) 
pandemic. The impact of HIV disease on children is not limited to their increasing rates 
of  infection,  but  also  to  the  fact  that  in  10  years  time  over  40  million  children  are 
expected to be orphaned as a result of AIDS45. HIV infection is posing a life long threat 
to children, with over 500,000 infected as of 2005138,139. 
  Three important factors influencing epidemiology of pediatric HIV infection are: 
(1) The prevalence of HIV among women in childbearing age (2) The availability and 
effective  use  of  antiretroviral  and  prophylactic  therapy for  children  (3)  Institution  of 
antiretroviral medications during pregnancy. Almost half of all infected individuals are 
women of childbearing age25, 45. Little or no antiretroviral medications are available for 
these women. Also children in developing countries do not have access to life-saving 
drugs.  In  contrast  the  picture  is  very  different  in  the  developed  countries  as  testing 
pregnant women for HIV infection and institution of antiretroviral  medications during 
pregnancy for HIV-infected women are becoming common practices25, 45. 
Vertically acquired HIV infection accounts for 85% of all reported pediatric cases 
world wide25,  45.  The vertical  transmission can occur in several  ways:  maternal  bodily 
fluids  during  labour  and  delivery,  breast  feeding  and  through  the  placenta  early  in 
gestation25, 45. These are multiple determinants of transmission and include maternal viral 
load, viral phenotype, obstetric factors and maternal immune response25, 45 
Following the initial report in 1982 of HIV infection in children it became evident 
that the clinical characteristics of HIV infection in children were different from those of 
adults. In 1987, CDC published a classification system for children infected with HIV. 
The classification system categorized clinical manifestation of HIV infection in children 
based  on  limited  data  available  early  in  epidemic19.  New  knowledge  about  the 
progression of HIV disease among children warranted revision of the 1987 classification 
system to reflect the disease process better. In 1994, CDC convened a working group of 
public health service to revise of the pediatric HIV infection classification system. They 
system  classified  pediatric  HIV  infection  into  exclusive  categories  based  on  three 
parameters a) Infection status b) Clinical status and c) Immunologic status19. 
 In children, individual sign and symptoms are often non-specific. Unlike adults, 
vertically infected children have an immature immune system and consequently present 
with  a  shorter  incubation  period  and  more  rapid  and  fulminate  disease  process 
(Rosenberg and Fauci, 1994). Clinical presentation of orofacial lesions in patients with 
HIV infection is strongly associated with immune suppression25, 45.
Due to the profound immunosuppression HIV infected pediatric patients are more 
susceptible  to  opportunistic  infections  particularly  fungal  infections  like  candidiasis, 
cryptococcoidosis, histoplasmosis and aspergillosis  110. Of these candidiasis is the most 
common infection and occurs in 63% of the pediatric population56.         
Pseudomembranous  candidiasis  is  the  most  common  type  (Valdez  et  al  and 
Santos et  al) followed by erythematous type and angular chelitis45.  Candidia albicans, 
Candidia glabrata, Candidia tropicalis, Candidia dubliniensis and Candidia krusei have 
been associated with HIV infection  15,  54,  66,  111.  The conventional methods available  to 
isolate and subtype them involve significant technical expertise and are time consuming. 
Newer technique like CHROM agar help to identify different species15, 66. 
Oral lesions of HIV in adults are relatively well described in the literature but 
comparative  data  on  pediatric  HIV  infection  is  limited  particularly  in  developing 
countries like India 25, 44. 
Aims & Objective
HYPOTHESIS:
1. Oral lesions are a major feature of HIV seropositive pediatric patients.
2.  Candidiasis in HIV infection is due to Candidia albicans.
AIMS AND OBJECTIVES: 
1. To identify and document oral lesions in HIV seropositive pediatric patients.
2. To isolate candida from both symptomatic and asymptomatic HIV seropositive 
pediatric patients
3. To speciate and quantitate candidia in both symptomatic and asymptomatic HIV 
seropositive pediatric patients.
Review of Literature
“Pediatrics is a branch of medicine which is concerned with the health of infants, 
children and adolescents, their growth and development, and their opportunity to achieve 
full potential as adults."  By Richard E.Behrman 141
Pediatric dentistry definition was changed in July 1994 by the American dental 
association council, as “ It is an age defined speciality that provides both primary and 
speciality  comprehensive  preventive  and  therapeutic  oral  health  care  for  infants  and 
children through adolescence, including those with special health care needs”140 
PEDIATRIC HIV INFECTION   
Over the past decade, the global pandemic of HIV has spread to every continent, 
with  nearly  13million  cases  worldwide.  Of  these  cases  1  million  have  occurred  in 
children.  Since the first  childhood case was reported in 1983 the number of children 
infected with the HIV virus has grown almost exponentially. Pathogenesis of pediatric 
HIV is different from that of adult and it depends on multiple factors which include high 
viral load and lower CD4 cell count which reflect the maternal diseases45.
Geographical distribution: 
Kamal H and Rathore MH (1997)63  pediatric HIV infection continues to be a 
challenge for the medical community. It is an evolving entity and our knowledge of HIV 
is  increasing  rapidly  with  newer  finding.  Florida  is  the  second  highest  number  of 
pediatric AIDS cases among developed countries.
Grant AD and Cock KM (2001)49 the epidemiology and burden of HIV in the 
developing world are different than the HIV status in developed countries. Homosexual 
transmission is common route of transmission of HIV in developed countries were as 
vertical transmission (children) and heterosexual transmission is the common mode of 
transmission seen in the developing countries. HIV 2 infection is the common type of 
HIV seen in developed countries.
Rothrock SG (2004)113 over the past decade, the global pandemic HIV has spread 
to every continent,  with nearly 13 million cases world wide.  Classification system in 
child is based on the CD4 count level and the diagnosis is made only when the children is 
more than 12 months of age. The common clinical presentation varies according to the 
endemic areas.
Mahal A and Rao B (2005)82 India now appears on the brink of significant AIDS 
epidemic. More consideration is given to the clinical aspect of the diseases, but one of the 
major cause of spread of HIV infection in India is adverse household level economic 
status.  They  concluded  that  household-level  economic  status  has  an  impact  on  HIV 
infection in developing countries like India. 
Global AIDS Epidemic/ UNAIDS (2005)138 More than 1,900 children worldwide 
are infected with HIV each day. In 2005, an estimated 4.8 million people (range: 4.2-6.3 
million)  became  newly  infected  with  HIV --  630,000 of  them were  children  (range: 
570,000--740,000).  The vast  majority  of them were infected  antepartum (20% before 
childbirth;  during  pregnancy);  intrapartum  (40%  during  childbirth),  or  breastfeeding 
(40%). Today, some 37.8 million people (range: 34.6-42.3 million) are living with HIV -- 
2.1 million (range: 1.9-2.5 million) of them are children under the age of 15. In 2003, 2.9 
million people (range: 2.6-3.3 million) died of AIDS -- 490,000 (range: 440,000-580,000) 
were children. This amounts to approximately 1,350 AIDS deaths in children per day. 
Worldwide,  over  20  million  people  have  died  from AIDS since  the  first  cases  were 
identified in 1981. There are children orphaned by AIDS in almost every country of the 
world. Children orphaned by AIDS range in age from a few days or months old to 18 
years of age. In countries with low-level and concentrated epidemics, it is impossible to 
reliably  estimate  the  number  of  children  orphaned  by  AIDS,  or  to  determine  what 
percentage they represent of all orphans. By 2010, this number is expected to climb to 
more than 18 million.
NACO India (2005)139 Out of 1111608 HIV infected  patients  in  our  country, 
about 4854 are children and they are between the age group of 0-14 years. 
Classification:   
With the identification of causative agent of AIDS a broad spectrum of clinical 
manifestations  has been attributed to infection with HIV. With the expectation of the 
CDC  (Center  for  Diseases  Control)  surveillance  definition  for  AIDS,  no  standard 
definition for other manifestations of HIV infection has been developed for children19,29. 
First classification was published in 1987 based on the clinical presentation this 
classification system has been developed primarily to categorize clinical presentations in 
adult  patients  and  may  not  be  entirely  applicable  to  infants  and  children.  With  new 
knowledge about the progression of HIV disease among children warranted revision of 
the 1987 classification system to better reflect the disease process. New classification is 
based on infection  status,  clinical  status  and immunologic  status of the HIV infected 
children19, 29.
CDC 198729 Framed the first classification for HIV infected pediatric patients in 
to three groups which were based entirely on the clinical presentation.
CDC 199419 with the additional knowledge about the progression of HIV diseases 
among  children,  a  new classification  was  framed  which  categories  the  HIV infected 
children according to infection status, clinical status and immunological status. 
Marnino  LM, Tova PA, Gabiano C  et  al(2000)84 They compared  the  CDC 
pediatric classification system with the long time course of prenatal HIV type I infection, 
the  studied  366  prenatal  patients  starting  from birth  at  least  every  three  months  for 
mortality, manifestations etc. They observed that clinical status was comparable with the 
CDC classification but the immune status of infants and patients in categories B showed 
better prognosis than other categories.
Age distribution:   
Kamal H and Rathore MH (1997)63  Most of the children affected are between 
the age group of 4-7 years.
NACO India (2005)139 Out of 1111608 HIV infected patients in our country, 
about 4854 are children and they are between the age group of 0-14 years.
Pathogenesis:
Kamal H and Rathore MH (1997)63  pediatric HIV infection continues to be a 
challenge for the medical community. HIV infection progress in two general patterns in 
HIV infected patients;  first mode is rapid progression when severe immunodeficiency 
develops in the first year of life in 15-20% of children. The remaining 75% to 80% have a 
form of disease that progress slowly and more similar to that of adults.
Church JA (2000)26 HIV infection in children is different from that of an adult; it 
has  an  bimodal  pattern  of  progression  and there  is  no specific  CD4 that  defines  the 
condition unlike for patients over 13 years of age. HIV test can not do for children with in 
18months of life since most of the children born to HIV infected mothers will be positive 
till one year of life. They are more pronounced to bacterial infections than adults. 
Banerjee  U  (2005)4 Several  analyses  of  data  from  pediatric  registries  and 
retrospective studies  have  suggested  that  the  progression  of  the  acquired 
immunodeficiency syndrome (AIDS) follows two patterns in children who are infected 
with the human immunodeficiency virus by their mothers. In the first year of life, severe 
immunodeficiency develops and the other pattern is  a form of disease that  progresses 
more slowly and is probably similar to that observed in adults. They studied the influence 
of clinical and biologic characteristics of HIV-infected mothers at the time of delivery on 
the progression of disease and death in 162 infected children. They observed that infants 
whose HIV infection is maternally acquired, the rate of disease progression varies directly 
with the severity of the disease in the mother at the time of delivery.
Godbole S and Mehendale S (2005)46  since the first report of HIV infection in 
India in 1986, the virus has spread all over the country although there are geographic 
variations.  It  is  estimated  that   5.1million  people  are  infected  with  HIV.  Both  HIV 
serotypes 1 and 2 exist in India and HIV 1 C is the commonest subtype reported.
Route of transmission and prevention: 
Most children who are infected with HIV acquire the virus through mother-to-
child  transmission.  Without  any  intervention,  overall  mother-to-child  transmission 
(MTCT) rates range between 25% and 45% in developing countries, and between 16% 
and 20% in Europe and North America114. The prevalence and duration of breast-feeding, 
prematurity, and the maternal viral load, as well as the different methods used to classify 
infant infection status and calculate transmission rates, may account for the differences in 
reported perinatal HIV-1 transmission rates around the world. MTCT can occur during 
pregnancy – in utero or labour and delivery – intrapartum, and through breast-feeding – 
postpartum114. The  absolute  risk  for  in utero transmission  is  estimated  to  be 
approximately 5% to 6%, and for intrapartum transmission, approximately 13% to 18%. 
In  many  developing countries  where  breast-feeding  is  almost  universally  practiced, 
postpartum  transmission through  HIV-1  contaminated  breast  milk  has  been  widely 
documented114. 
Rutherford GW, Oliva GE, Grossman M et al(1987)115 the transmission of HIV 
infection from infected mothers to infants either utero or perinatally has been established. 
The  rate  of  transmission  in  developed  and  developing  countries  various.  Preinatal 
transmission can be avoided by educating the mother and with the availability of ART 
drugs.
Wara DW (1995)135 approximately 2% of people with AIDS in United States are 
children. More than 90% of children acquire HIV infection through vertical transmission. 
Administration of antiretroviral therapy during the delivery or 6week after delivery is the 
major way to prevent HIV infection in children.
Kamal H and Rathore MH (1997)63  pediatric HIV infection continues to be a 
challenge for the medical community. The predominant mode of transmission is through 
vertical transmission.
Raeza Dm (1999)108 compared the HIV infected children whose mothers were 
treated  with  antiretroviral  drug  with  children  whose  mother  were  not  treated  with 
antiretroviral drugs. They screened 216 Italian patients and estimated the probability of 
developing sever diseases or sever immune suppression. They found that 37.2% of first 
group had low chance of developing diseases than the other group of patients.
Jain  A and Davis  MM (2001)60 95% of  HIV infected  children  are  living  in 
developing countries. The major mode of transmission in them is vertical transmission. 
This  can  be  prevented  by  administration  of  antiretroviral  drugs  intravenously  during 
delivery or 6week after birth.
Hermione EG (2002)53  40 million people were infected with HIV infection and 
majority  were  in  South  Africa.  The  common  mode  of  transmission  was  vertical 
transmission and in breast fed children it is estimated to be 25-45% when compared to 
non breast fed children.
Black E and Robert CG (2002)13 Breast feeding continues to be the norm in low 
income countries, but the period of exclusive breast feeding after birth is often short. 
WHO recommended  6  month  of  breast  feeding  is  needed  to  protect  the  child  from 
endemic  diseases but with the recognition  that HIV can be transmitted from infected 
mothers  to  their  infants  through  breast  milk.  In  order  to  prevent  HIV  transmission 
affordable and safe infant formula food, withholding breast milk is recommended. 
Steinbrook R (2002)121 most of the children who are infected with HIV infection 
were through perinatal  transmission.  With the admistration of Antiretroviral  drug, the 
perinatal transmission can be prevented. 
Godbole S and Mehendale S (2005)46 Mother to infants transmission is 36-48% 
in India. It has been reported that 63% of multi-transposed thalassaemic HIV infected 
children became symptomatic in infancy with a 9% fatality rate with in 14 months of age. 
Antiretroviral therapy is given to the pregnant women from the last 6weeks and delivered 
by elective caesarians section.
Investigations:
Clogg D, Delage G, Halperin S (1993)27 when the patient develop symptoms like 
diarrhea, unknown fever, lymphadenopathy, hepatomegaly, the child should be tested for 
HIV infections and it is usually done for those patients who are more than 18 months of 
age since children born to HIV infected mothers will be positive if tested within one year 
of age; so there are possibility of false positive results. 
Villalobos TI (1999)131 significant changes have occurred in management of HIV 
infection in children since the first case was reported in 1983. But it still continues to be 
one of the leading causes of death in children. It progresses in bimodal way and the major 
mode of transmission is by vertical transmission. Antibody testing in infant is usually 
done after 18months of age. Perinatally admistration of antiretroviral drug will help to 
reduce the transmission of HIV infection from the mother to child.
Church JA (2000)26 HIV infection in children is different form that of an adult; it 
has an bimodal pattern of progression, there is no specific CD4 that defines the condition, 
in patients over 13 years of age. HIV test can not be done for children with in 18months 
of life since most of the children born to HIV infected mother will be positive till one 
year of life. They are more pronounced to bacterial infections than adults. 
Weinberg A and Pott GB (2003)136 they correlated CD4 count, cell mediated 
immunity in 12 patients who were on antiretroviral therapy. They found that there is an 
significant correlation between the degree of CD4 count and the effect of antiretroviral 
therapy. 
Ramesh SP (2005)104  Even though the prognosis of HIV is decided by plasma 
virus load set point, the rate of decline in CD4 count, increase in plasma virus load and 
the HIV associated opportunistic infections. HIV specific CD4 helper response and HIV-
specific CTL responses clearly emerge as the most important host factors that may decide 
the rate of disease prognosis.
ORAL LESION IN HIV PEDIATRIC
Infection with HIV results in profound immunosuppression and render the host 
susceptible  to  the  development  of  various  opportunistic  infections  and  neoplasms91. 
Compared  with  adult,  the  progression  of  HIV infection  is  more  rapid  and  severe  in 
infants and children due to the ongoing development of different organ system and an 
immature immune system that is less resistant to infection 22. Oral lesions are frequently 
the first symptoms in HIV infected children. Early detection of HIV related oral lesions 
could be used to diagnose HIV infection,  elucidate progression of the disease, predict 
immune status, and provide timely therapeutic intervention107, 91. Using the frame work of 
EC-Clearinghouse and WHO a consensus classification of oral  lesion associated with 
pediatric HIV infected patients was formed in 1994 97
Ferguson FS, Berenten B, Nachman S (1995)35  studied oral manifestations in 
58 HIV infected patients and found that pseudomembraneous candidiasis was observed in 
29% of cases, parotid gland swelling is seen in 23.5% of cases, gingival inflammation 
was seen in 5.2% of cases and hairy leukoplakia was seen in 3.2% of cases. They found 
that incidence of dental caries was more in patients with decreased immune status.
Leggott PJ (1995)74 stated that in adults, oral lesions are frequently noted among 
HIV infected children. The most common fungal infection observed was oral candidiasis 
seen  in  11%-72%  in  symptomatic  patients  and  11%-20%  in  asymptomatic  patients. 
Presence of oral candidiasis indicate the immunosuppression state of the children. Other 
fungal infections associated with HIV infected patients are crytococcosis, histoplasmosis, 
geotrichosis and aspergillosis. The common viral lesion seen in them are herpes simplex 
virus (24%), herpes zoster and oral hairy leukoplakia caused by Epstein-bar virus. The 
neoplasms among the children are kaposis sarcoma, non- Hodgkins lymphoma which is 
less prevalent when compared to adult HIV infected patients. 
Broder HL, Catalanotto FA, Reisine S et al(1996)17 did a longitudinal study to 
examine the compliance rate among HIV positive patients;  HIV negative patients  and 
HIV- positive siblings. 105 patients were screened. The major complaint in them was 
dental  caries,  oral pain and gingivitis.  Each patient was followed for every 6 months. 
They  found  that  the  children  with  HIV  and  their  siblings  have  significantly  lower 
compliance  than  the  regular  patients.  This  is  indicated  the  need  for  improving  our 
understanding to care for HIV infected children.
Chigurupati R, Raghavan SS, Deborah A (1996)25 reviewed the common oral 
manifestations  observed in  HIV infection pediatric  patients.  Oral  candidiasis,  herpetic 
eruptions,  oral  hairy  leukoplakia,  oral  ulcers,  linear  gingival  erythema,  cervical 
lymphadenopathy were the common oral lesions seen in HIV infected children.
Howell  RB,  Jandinski  JJ,  Palumbo  P  et  al(1996)57 studied  the  oral 
manifestation in 60 HIV positive children in USA and correlated the prevalence of oral 
lesion with the CD4 count. Oral candidiasis in 32% of cases, conventional gingivitis in 
45% of patients, linear gingival erythema in 38% of cases and periodontitis was observed 
in 8% of cases. They observed a significant difference between the prevalence of oral 
candidiasis,  healthy  gingival  and  periodontitis  and  the  CD4 count  but  there  was  no 
relationship between the linear gingival erythema, conventional gingivitis and the CD4 
count. They concluded that with the decline in the CD4 count they is an definite increase 
in prevalence and severity of candidiasis and gingivitis.
Ramos F, Hiltons JS, Greenspan JS  et al(1996)107 retrospective study on 492 
perinatally infected HIV pediatric patients in California. They   were screened in order to 
find the prevalence of oral facial soft tissue manifestations in HIV infected children and 
normal children and also to identify the risk factor for occurrence of oral lesions. 91 HIV 
infected children and 185 HIV negative children were taken. Oropharyngeal candidiasis 
was seen in 67%, parotid gland enlargement was seen in 19%, herpes simplex virus in 
3% of patients. They conclude that the occurrence of oropharyngeal candidias in children 
is due to presence of vaginal candidiais during delivery and this lesion could be used as 
one of the indicators for risk factor determination in HIV infected children.
Toro AD, Berkowitz R, Meyerowitz C et al(1996)127 screened 28 HIV infected 
patients in New York to find the prevalence of oral lesion in them. Pseudomembraneous 
candidiasis was seen in 27.8% of patients, ulcer in 7.1%, delayed tooth development in 
7.1% of cases, parotid swelling in 5.5% and petechiae was seen in 39.3% of cases. 
Luciance RR, Peacock CS, Hounnou A et al(1998)77 screened 40 HIV positive 
Brazilian  pediatric  patients  to  find  the  prevalence  of  oral  lesion  in  them.  Cervical 
lymphadenopathy  was  the  most  common  lesion  observed  in  them  followed  by 
pseudomembraneous candidiasis in 22% of patients, angular chelitis in 9.8% of cases, 
erythematous candidiasis in 4.9% of cases and ulcer in 4.9% of patients.
Reddy BV, Ranganathan K, Kumarasamy N et al(1998)109  screened 13 HIV 
positive  pediatric  patients  in  Chennai.  The  prevalent  oral  lesions  observed  were 
Pseudomembranous  candidiasis,  erythematous  candidiasis,  chronic  gingivitis,  apthous 
ulcers,  parotitis,  lymphadenopathy.  The  common  systemic  lesions  were  pulmonary 
tuberculosis,  herpes  zoster,  lymphadenopathy,  lower  respiratory  tract  infections  and 
staphylococcal skin infections. 
Vieria AR, Riberiro LP, Modesto AC et al(1998)130 studied the gingival health 
in 43 HIV positive patients in Brazil. They found that the severity of gingival diseases is 
more in patients with severe immunosuppression state and had high prevalence of dental 
caries.
Arendorf T and Holmes H (2000)3 studied the various oral manifestation seen in 
HIV infected adult patients. They are different in the developed and developing countries 
but  this  data  is  not  available  for  HIV  infected  pediatric  patients.  Malnutrition  and 
nutritional  deficiencies,  especially  protein  energy malnutrition  is  common  in  patients 
infected with HIV but pneumocystis carinii is common in the developed countries.    
Baransch A, Safford M, Catalanotto FA et al(2000)5 did a longitudinal study 
for two years in New York, to compare the various oral manifestations in HIV positive 
and  HIV  negative  patients.  104  HIV  positive  patients  were  screened. 
Pseudomembraneous candidiasis was seen in 19% of patients, atrophic candidiasis was 
seen  in  9%,  linear  gingival  erythema  in  22%,  median  rhomboid  glossitis  in  12%, 
conventional gingivitis in 7%, necrotizing periodontitis in 3.8% and hairy leukoplakia in 
2%. They concluded that oral candidiais was the common oral lesion observed in HIV 
infected children and it can be used to asses the disease progression and immune status 
but it is a poor indicator for mortality.
Dos  LD,  Fernanda  G,  Riberiro  LP  et  al(2000)30 screened  80  HIV infected 
Brazilian  pediatric  patients  in  order  to  correlate  the  oral  lesions  with  the  degree  of 
immunosuppression. They observed 38% of oral lesions in patients with low CD4 count. 
The common oral lesion observed in them was oral candidiasis in 22.5% patients, 17.5 % 
had gingivitis, parotid gland enlargement was observed in 8.8% of cases, herpes simplex 
was seen in 1.3% of cases and hairy leukoplakia was observed in 1.3% of cases.
Eldridge K and Gallagher JE (2000)33 screened 30 HIV positive children and 20 
HIV negative children in London to evaluate dental caries prevalence in these groups. 
They observed that the prevalence of dental caries in positive children is 60% more than 
non  infected  children  and  this  is  because  of  unfavorable  dental  behaviors  like 
consumption of extrinsic sugar in night, use of sugar based medications,  low fluoride 
intake, late commencement of tooth brushing and poor dental attendance. 
Flanagan MA, Barasch A, Koenigsberg SR et al(2000)39 studied the prevalence 
of  oral  manifestation  in  38  HIV infected  pediatric  patients  treated  with  antiretroviral 
therapy.  Oral candidiaisis in 36 % of cases, conventional gingivitis in 50% of patients, 
linear gingival erythema in 32% of case, median rhomboid glossitis in 8%, parotitis in 
3% of cases, herpes labialis and hepetic gingivitis in 3% of cases are the common lesions 
observed  in  their  study.  They  concluded  that  there  is  no  significant  difference  in 
prevalence of oral lesion in patients with HAART and without HAART.
Gelbier M, Lucas VS, Zervous NE et al(2000)44 studied the prevalence of dental 
caries and gingival diseases in 35 HIV positive patients in London. Dental caries was 
more  common  in  deciduous  tooth  than  in  permanent  tooth  and  60% of  patient  had 
gingivitis. Other common oral lesions observed in their study were pseudomembraneous 
candidiasis, erythematous candidiasis and one case of hyperplastic candidiasis.
Gomez FJ, Petru JF, Hilton AJ  et al(2000)47 did a retrospective study in 40 
perinatally HIV infected children in California to describe the incidence and prevalence 
of oral manifestations in them. They found that the incidence of oral candidiasis was 43% 
and was positively associated with the low CD4 count and occurrence of plaque, and they 
observed  that  in  patients  with  severe  immunosuppression  there  was  delayed  tooth 
eruption and high incidence of dental caries.
Hicks MJ, Flaitz CM, Carter AB et al(2000)55 did a descriptive longitudinal 
clinical study in 73 HIV infected children to determine caries in primary and permanent 
dentition and compared it with CD4 immune status. They observed that primary caries 
increases with decrease in CD4 count and the caries free state decrease with increase in 
age and decrease in immune status. This is due to admistration of high carbohydrate diet 
in HIV infection patients in order to improve their health status and the use of sugar rich 
medication.
Konzinetz CA, Carter B, Simon C et al(2000)70 assessed the prevalence of oral 
lesion in 73 HIV positive pediatric patients in Brazil. The predominant lesion observed 
was cervical lymphadenopathy seen in 51% of cases, hairy leukoplakia in 3% of cases, 
parotid gland enlargement was seen in 12% of cases, oral candidiasis was seen in 41% of 
cases, and xerostomia was seen in 44% of cases. They also observed that the severity of 
oral lesion increases with the decreases in immune status.
Oralloda  WS and Talmitis  NI (2000)95 screened 762 HIV positive  pediatric 
patients for oral lesions. The common oral lesion observed were 18.42% oral candidiasis, 
28.9% angular cheilitis, conventional gingivitis in 13.1%, herpes simplex in 5.2%, hairy 
leukoplakia, recurrent ulcers and condyloma in 2.63%. Enamel hypoplasia was seen in 
23.6% of cases. 
Schoen DH, Murray PA, Nelson E et al(2000)117 A longitudinal study was done 
to compare the periodontal diseases in 68 HIV infected and 53 household peers. They 
found that occurrence of linear gingival erythema is more common in the HIV positive 
group. 
Tofsky N, Nelson EM, Lopez RN et al(2000)126 studied the prevalence of dental 
caries between 104 HIV positive and 67 HIV negative pediatric patients in New York 
population. They found that the incidence of caries is 17% higher than the negative group 
and the incidence of caries is more in patients between the age group of 6-11years and in 
deciduous teeth. This is due to unfavorable dental habits and also due to delay in eruption 
of permanent teeth.
Flatiz C, Wullbrands B, Sexton J et al(2001)36  studied the prevalence of oral 
lesions in 173 HIV infected Romanian pediatric patients. The most common oral lesion 
observed was oral candidiasis in 29 % of cases, ulcers in 15% of cases, parotid gland 
enlargement  in  9% of  cases,  necrotizing  ulcerative  gingivitis  in  5% of  cases,  linear 
gingival erythema in 4% of cases, labial molluscum contagiosum in 3% of cases, oral 
wart in 2% of cases, hairy leukoplakia in 2% of cases and herpes zoster in 1% of patients. 
Dental caries was present in 46% of cases.
Hauk  MJ,  Moss  ME,  Weinberg  GA  et  al(2001)51 assessed  the  relationship 
between delayed tooth eruption and the progression of pediatric HIV infections to AIDS 
in 70 perinatally infected children in New York. They did an analysis between the dental 
age  and  chronological  age  and  found  that  the  clinical  symptom  status  was  strongly 
associated with the delayed tooth eruption in 60% of cases but there was no significant 
association  between  CD4 level  and  delayed  tooth  eruption.  They  concluded  that  the 
delayed tooth eruption is due to the severity of symptoms and not due to CD4 depletion.
Kozinetz CA, Matusa R, Cazacu A et al(2001)71 did a cross-sectional study in 
Romania  to  observe  the  predominant  oral  lesion  seen  in  762  HIV  positive  patients. 
Lymphadenopathy 100%, otitis media 97%, pneumonia 50%, candidiasis 68%, lymphoid 
interstitial  pneumonia  50%,  recurrent  herpetic  eruptions  50%,  recurrent  bacterial 
infection 97%, kaposis sarcoma in 2 cases.
Birnbaum  W,  Hodgson  TA,  Reichart  PA  et  al(2002)12 studied  the  oral 
manifestation of HIV infection has been considered to be of value in assessing diseases 
progression  in  the  developed  country,  however,  the  potential  use  of  oral  lesions  as 
prognostic markers in developing countries is yet to be investigated this is due to less 
availability of dates from the developing countries.  With the introduction of HARRT 
therapy a vast change in prevalence of oral lesions. There is regression in the occurrence 
of oral candidiasis, kaposis sarcomas and oral hairy leucoplakia.  However there is no 
change in the prevalence  of oral  condylomata  and herpes  simplex  infections.  Further 
research should be conducted in developing countries to know the real status of HIV in 
the world.
Gomez  FR  (2002)48 stated  that  oral  lesions  are  early  and  common  clinical 
indicators and progression markers of HIV infection. The common oral lesions are oral 
candidiasis,  of  which  pseudomembranous  candidiasis  was  common  followed  by 
erythematous candidiasis and hyperplastic candidiasis.  The prevalence of other lesions 
like parotid gland enlargement is 10-30% and herpes simplex is 1.7-24%. Periodontal 
lesions commonly seen in HIV infected children are linear gingival erythema, necrotizing 
ulcerative  gingivitis,  necrotizing  ulcerative  periodontitis  and  necrotizing  ulcerative 
stomatitis.  Dental  caries  is  common  in  these  patients  due  to  drugs  and  due  to 
immunosuppression. Rare lesions seen in the pediatric group are oral hairy leukoplakia, 
kaposis sarcoma and non-Hodgkins lymphoma.  
Patton  LL,  Phelan  JA,  Gomez  FJ  et  al(2002)97 reviewed  the  common  oral 
lesions between HIV positive adults and pediatric patients. The common lesion in both 
children  and  adults  are  Non-CNS  opportunistic  infections,  Chronic  mucocutaneous 
candidiasis,  Neural  abnormalities,  Chronic  fever  and  diarrhea,  Diffuse  adenopathy, 
Hepatomegaly, Chronic eczema, renal diseases and cardiomyopathy. The lesion common 
in  childrens  than  in  adults  are  recurrent  bacterial  infections,  chronic  interstitial 
pneumonia, acquired microcephaly and failure to thrive. 
Teo CG (2002)124 stated that in the global terms, the two principal viral associated 
oral diseases in HIV infected patients are oral hairy leukoplakia and kaposis sarcoma. 
Both  are  prominent  in  America,  Europe  and  Australia  but  appear  to  be  less  among 
patients  in  south  Asia  and  Far  East.  In  Africa  AIDS  associated  kaposis  sarcoma  is 
commonly encountered but the prevalence figure for OHL varies considerably.
Mark WK (2003)83  did a cross-sectional study from the year 1990-1994 in 158 
patients,  the common oral  lesions observed in his study were, oral  candidiasis in 117 
patients,  herpetic  eruptions  in  20  patients,  apthous  ulcer  in  23  patients,  parotid 
enlargement  in  9  patients.  He  stated  that  variety  of  infectious,  neoplastic  and 
inflammatory conditions can produce cutaneous or oral lesions in HIV infected patients. 
Oral  hairy  leukoplakia,  bacillary  angiomatosis,  kaposis  sarcoma  are  common  lesion 
observed  exclusively  in  HIV  infected  patients,  herpes  simplex  virus,  varicella-zoster 
virus,  molluscum  contagiosum,  candidiaisis,  scabies  dermatitis,  apthous  ulcers, 
periodontal diseases, staphylococcal infections are the lesions that occur with severity in 
HIV infection.
Okunseri  C, Badner V,  Wiznia  A  et  al (2003)94 screened 102 HIV infected 
pediatric patients in New York and compared with the CD4 levels. 69% had oral lesions 
and  31%  were  disease  free.  The  common  oral  lesions  observed  were  conventional 
gingivitis 20.6%, pseudomembranous candidiasis 2.9%, depapillation of tongue 13.7%, 
median rhomboid glossitis 1%, bilateral parotid gland enlargement 2%, lymphadenopathy 
1%, linear gingival errythema in 2.9% and dental caries in 2.9%. Patients with low CD4 
count  had  more  gingival  lesions  than  the  other  two  groups,  which  was  statistically 
significant. They concluded that children with low CD4 count had more oral lesions.
Pongsiriwet  S,  Lamaroon  A,  Kanjanavanit  S  et  al(2003)102 described  the 
prevalence  of  oral  lesions  and  dental  caries  in  40  HIV  infected  Thailand  pediatric 
patients. Oral candidiasis was the most common oral lesion observed in 45% of cases and 
the Pseudomembraneous candidiasis was the common variant of candidiasis observed in 
32.5% of  cases,  erythematous  candidiasis  in  25  % of  patients,  angular  cheilitis  in  4 
patients, linear gingival erythema in 20% of cases and recurrent aphthous ulcer was seen 
in 5% of cases. Dental caries was seen more in the patients between the age group of 6-9 
years.
Reichart  PA  (2003)110 said  that  the  most  common  fungal  infection  in  HIV 
infected  patients  is  oral  candidiasis  and is  strongly  associated  with  HIV infection.  It 
occurs  in  9-90%  of  cases  and  the  most  common  variants  are  pseudomembraneous 
candidiasis  and erythematous candidiasis.  Common oral  bacterial  lesions seen in HIV 
infection  are  periodontal  lesions  like  linear  gingival  erythema,  necrotizing  ulcerative 
gingivitis and necrotizing ulcerative periodontitis. Kaposis sarcoma predominately occurs 
on the palate and tongue and is observed in 60% of adult HIV infected patients and rare 
in  HIV  infected  pediatric  group.  With  the  introduction  of  HARRT  therapy  the  oral 
manifestations such as oral  candidiasis,  gingivo-periodontitis  and kaposis sarcoma are 
rarely seen. 
Nadioo S and Chikte U  et al(2004)91 studied the various oral manifestation in 
169 HIV infected  hospitalized  patients  in  South  Africa  and compared  them with  the 
institutional  population.  They  found  pseudomembraneous  candidiasis  in  50%, 
erythematous candidiasis in 29%, angular chelitis in 10%, hairy leukoplakia in 1 case, 
cervical  lymphadenopathy  in  18%,  and  parotid  gland  enlargement  in  7  cases.  The 
prevalence  of  these  lesions  are  four  times  more  in  hospitalized  patients  than  in 
institutional patients but the prevalence of oral ulcer is more in institutional patients.
Glick M (2005)45 Although many clinical features are common to both adult and 
children,  lesions  like  failure  to  thrive,  abnormal  growth  rate,  lymphoid  interstitial 
pneumonia,  invasive  and  recurrent  bacterial  infections,  parotitis  are  pronounced  only 
among the pediatric population. The common malignancies in children are non-Hodgkins 
lymphoma and leiomyosarcoma. Kaposis sarcoma is common in adults but it is rare in 
children.  The  common  oral  lesions  are  oral  candidiasis,  parotid  gland  enlargement, 
lymphadenopathy.  The prevalence of orofacial manifestation differs among geographic 
regions and this is due to the level of medical care provided to the HIV infected children.
SYSTEMIC LESIONS AND ITS PREVALENCE IN HIV PEDIATRIC PATIENTS 
HIV infection has become one of the greatest pandemics ever. Young infants may present 
with sign and symptoms of HIV infection that strongly suggest intrauterine infection; 
other  children  may  show  no  outward  signs  of  HIV  for  more  than  10  years  26.  The 
common clinical presentation seen in HIV infected pediatric patients are chronic diarrhea, 
delayed  development,  failure  to  thrive,  hepatomegaly,  lymphadenopathy, 
lymphomas,opportunistic infections, recurrent otitis media, sinusitis, pneumonia, severe 
molluscum contagiosum or condylomas, splenomagaly, herpetic infection and other viral 
infections26.  The  clinical  presentation  various  depending  upon  the  severity  of 
immunosuppression2, 91, 57.  
Theuer  CP  (1989)125 Tuberculosis  is  a  frequent  complication  of  human 
immunodeficiency  virus  (HIV)-induced  immunosuppression.  The  diagnosis  of 
extrapulmonary tuberculosis  in patients  with evidence of HIV infection qualifies  as a 
criterion of the acquired immunodeficiency syndrome.  Demographic characteristics  of 
patients  with tuberculosis  and HIV infection vary by region and reflect  the degree to 
which patients with Mycobacterium tuberculosis infection adopt behaviors that put them 
at risk for HIV infection.   Treatment  is effective for tuberculosis  in HIV-seropositive 
patients, Isoniazid prophylaxis is recommended for HIV-infected patients with positive 
tuberculin skin tests.
Jones DS (1992)62 studied 44 HIV infected children in Palm Beach country to 
estimate the prevalence of tuberculosis in them. They observed 36% of children were 
infected with tuberculosis and had pulmonary type of tuberculosis and also there was a 
increase in number of tuberculosis patients each year.  They concluded that, largest effect 
of  the HIV epidemic  on tuberculosis  in  children  appeared  to  be indirect,  through an 
increase in the number of adults with active tuberculosis serving as potential sources of 
tuberculosis infection for children.
Chan SB (1996)24 studied the presentation of tuberculosis  in 12 HIV infected 
pediatric patients in New York, the frequent presenting symptoms were fever (75%) and 
tachypnea (33%). Extrapulmonary TB was present in 3 cases (25%) and 4 cases (33%) of 
pulmonary tuberculosis. He concluded that children with AIDS and TB most frequently 
present  with  atypical  manifestations  of  TB.  A  high  index  of  suspicion  is  needed  to 
correctly diagnose TB in this group of children.  Early diagnosis is important because 
most respond well when treated appropriately.
Lucas SB, Peacock CS, Hounnou A et al(1996)76 studied clinical presentations 
in 78 HIV infected pediatric patients  in Abidjan. They observed pneumocystis  carinii 
pneumonia,  measles,  pyogenic  meningitis  were  the  most  common  systemic  lesions 
among the HIV positive patients and prevalence of tuberculosis, lymphocytic interstitial 
pneumonia and encephalitis were also seen in HIV positive patients.
Nielsen K, Mcsherry G, Petru A  et al(1997)92   screened 143 perinatally HIV 
infected  pediatric  patients  in  New  Jersy.  Recurrent  bacterial  infections,  lymphoid 
interstitial pneumonia, wasting syndrome, mycobacterium avium infections, disseminated 
candida  infections,  pneumocystis  carinii  pneumonia,  disseminated  herpes  simplex 
infections,  disseminated cytomegalovirus infection,  tuberculosis, cryptoccosis were the 
common clinical presentations seen in the HIV infected patients.
Reddy BV, Ranganathan K, Kumarasamy N et al(1998)109  screened 13 HIV 
positive  pediatric  patients  in  Chennai.  The  common systemic  lesion  were pulmonary 
tuberculosis,  herpes  zoster,  lymphadenopathy,  lower  respiratory  tract  infections, 
staphylococcal skin infections. 
Spira R, Lepage P, Msellati P et al(1999)119 screened 218 HIV positive pediatric 
patients  in Rwanda to assess the various systemic manifestations in HIV infected and 
uninfected  pediatric  patients.  Oral  candidiasis,  chronic  parotitis,  hepatomegaly, 
generalized dermatitis, chronic fever, chronic diarrhea, lymphoid interstitial pneumonia, 
splenomegaly, lymphadenopathy, severe pneumonia, failure to thrive and chronic cough 
were the prevalent systemic presentations seen in their study.
Dray SR, Lepage P, Dabis F (2000)31 studied the common systemic presentation 
in  HIV pediatric  patients  in  Africa.  The  common  lesion  observed were  tuberculosis, 
which is the major cause for morbidity in the country. Common viral infections seen in 
them  were  measles,  herpes  zoster  and  herpes  simplex  infection.   Pneumonia  and 
influenza  were  the  common  bacterial  infection  observed  in  Africa  and  the  common 
opportunistic  infection  was candidiasis.  They conclude that  the rate  of morbidity  and 
mortality in Africa can be reduced if the availability of antiretroviral drugs is increased 
and  efficacy  measures  should  be  taken  to  reduce  the  perinatal  transmission  of  HIV 
infection.
Lodha R, Singhal T, Jain Y  et al(2000)75 studied various clinical presentation 
seen in 27 HIV positive pediatric patients in New Delhi (India). The common clinical 
presentation seen in there study was failure to thrive in all patients, fever in 95.4% of 
patients,  recurrent  and  persistent  lower  respiratory  tract  infection  in  86.4% of  cases, 
diarrhea  in  45.5%  of  patients,  lymphadenopathy  was  seen  in  40%  of  cases.  Other 
systemic  lesions  observed  were  hepatomegaly,  oral  candidiasis,  splenomegaly, 
disseminated TB and bronchiectasis.
Agarwal  M,  Koppikar  GV,  Ghildiya  Ri  et  al(2001)2 studied  the  clinical 
presentation in 821 HIV positive pediatric patients in Mumbai (India). Most of the patient 
in  the  study were  between  the  age  group  of  1-3  years  and  the  predominant  clinical 
presentation observed in their study was chronic diarrhoea and disseminated tuberculosis. 
They concluded that the clinical presentation seen in HIV infected patients could be an 
additional pick up for detection of new HIV positive pediatric patients.
Palme ID (2001)96   studied risk factors associated with seropositivity for HIV in 
Ethiopian children with clinical TB.  HIV prevalence among children with clinical TB 
was 11.2%. High educational status of mothers, low age, loss of one or two parents and 
earlier  Calmette-Guerin  bacillus  (BCG)  vaccination  of  the  child  were  factors 
independently related to HIV infection.   They concluded that  the higher education of 
parents, higher income and better living conditions may be the risk factors associated 
with TB seen in HIV infected pediatric patients.
Merchant RH, Oswal JS, Bhagwat RV et al(2001)87 studied various systemic 
lesions  in  285  HIV  positive  pediatric  patients  from various  urban  areas  in  Mumbai 
(India).  Vertical  mode  of  transmission  was  the  most  common  mode  acquiring  HIV 
infection in their  study.  Most of the children infected were between the age group of 
2-5years of age. The most common clinical presentation are protein energy malnutrition 
in  127 patients,  pulmonary  and extrapulmonary  tuberculosis  seen  in  29.4% of  cases, 
hepatomegaly in 28.7% of cases, generalized lymphadenopathy in 67 patients, skin lesion 
in 22.10% of cases. Other lesions observed were chronic diarrhea, oral thrush, unknown 
pyrexia, chronic lung disease, chronic parotitis, otitis media, recurrent lower respiratory 
tract  infection,  pneumocystis  carniii  pneumonia  were the common lesion observed in 
their study.
Puthanakit T and Sirisanthana V (2003)105  in their retrospective study of 122 
Thailand pedatirc HIV positive patients found that there was a decline in the number of 
cases reported with pneumonia but there is a marked increase in the incidence of TB in 
their country and this could be due to availability of antiviral drugs. 
Matid  LH,  Marcopito  LF,  Succi  RC  et  al(2004)86 studied  the  clinical 
presentation in 914 HIV infected pediatric patients in Brazil. Multiple bacterial infection, 
pnemocystis  carinii  pneumonia,  bacterial  meningitis  and  interstitial  lymphocytic 
pneumonia were the common presentations seen in their study.
Swaminathan  (2004)122 said  that  tuberculosis  (TB)  is  the  most  common 
opportunistic  infection  in  human  immunodeficiency  virus  (HIV)-infected  people 
worldwide.  HIV-positive  children  are  at  risk  of  diagnostic  error  as  well  as  delayed 
diagnosis of TB because of overlapping clinical and radiographic features with other lung 
diseases like Acute pneumonias  and chronic lung diseases such as bronchiectasis  and 
lymphocytic interstitial pneumonitis. TB manifestations are more severe in HIV-positive 
children and progression to death is more rapid than in HIV-negative children. He studied 
62 children HIV positive children in Chennai, majority of them present clinically with 
pulmonary and extrapulmonary tuberculosis.
Aghamohammadi  A,  Farhoudi  A,  Moin  M  et  al(2005)1 screened  65  HIV 
positive Iranian pediatric patients. The most common systemic presentation in them was 
otitis media, diarrhea, pneumonia, sinusitis, respiratory diseases and recurrent bacterial 
infections.
Bavedekar  SB and Agarwal  R (2005)8 aimed  to  study the  various  systemic 
lesion in HIV infected patients  and to find out the possible risk factor in them. They 
screened 115 HIV positive  children  in  a  hospital  at  Mumbai.  Chronic  fever,  chronic 
diarrhea,  servere  malnutrition,  persistent  cough,  oral  thrush,  generalized 
lymphadenopathy, generalized dermatitis, hepatomegaly, disseminated tuberculosis, were 
the  common  systemic  infection  observed  in  their  study  group.  They  found  that  oral 
thrush,  generalized  dermatitis  and  generalized  lymphadenopathy  were  the  significant 
independent clinical risk factors for predicting HIV seropositivity.
Kumarasamy N, Vallabhaneni S, Flanigan TP et al(2005)73  67 to 87 per cent of 
pediatric HIV infection is by Vertical transmission. Perinatally infected children become 
symptomatic by five years of age. Failure to thrive is the most common clinical condition 
associated  with  pulmonary  and  extra  pulmonary  tuberculosis.  The  most  frequent 
opportunistic infection, oral candidiasis, hepatosplenomegaly, recurrent respiratory tract 
infection, Pneumocystis carinii pneumonia, chronic lung disease, persistent generalized 
lymphadenopathy,  chronic diarrhoea, pyrexia of unknown origin, chronic hypertrophic 
parotitis, chronic ottorrhoea, bacterial skin infection, and PPE were noted .HIV epidemic 
grows and , it is important for primary care physicians to learn to suspect and test for HIV 
infection. Early  detection  of  HIV  optimizes  chemoprophylaxis  for  opportunistic 
infections  and  provides  an  opportunity  for  secondary  HIV  prevention,  with  the 
availability of HAART; treatment can vastly reduce morbidity and mortality in Indian 
patients.
CANDIDA IN HIV INFECTED PATIENTS 
Oropharyngeal candidiasis may occur in up to 90% of human immunodeficiency 
virus (HIV)-infected patients during the course of the disease32 Progressive cell-mediated 
immunodeficiency with decrease of CD4+ lymphocyte count to ≤ 200 cells/mm3 is a 
major risk factor for colonization with Candida species and development of candidiasis74. 
Clinically,  OPC in HIV infection has been classified as exhibiting pseudomembranous 
and erythematous variants, or angular cheilitis
Epstein JB, Pearsall NN, Truelove EL (1980)34  studied the CFU count in HIV 
positive adults and found that patients with candidiasis had >400 colony-forming units 
per ml of saliva, whereas carriers of candida albicans had <400 colony-forming units per 
ml. Thus, quantitative cultures of saliva may aid in the diagnosis of oral candidiasis.
Challacombe SJ (1994)23 stated that candida infection in human is complex and 
both  humoral  immunity  and  cell  mediated  immunity  place  a  major  role.  Humoral 
immunity  is  protective  by  salivary  antibodies  and  serum  antibodies,  which  prevents 
adhesion  of  the  fungi.  Cell  mediated  immunity  plays  a  role  particularly  in  chronic 
hyperplastic candidiasis.
Lynch DP and Teen M (1994)78 Candida albicans is ubiquitous dimorphous yeast 
and  has  the  potential  to  cause  human  diseases  under  specific  circumstances  and 
conditions. The usual presentation is pseudomembraneous candidiasis and erythematous 
candidiasis.  
Soll  DR,  Morrow B,  Srikantha T (1994)118 stated  that  candida  albicans  and 
related species switch frequently and reversibly between a number of general phenotypes 
usually discriminated by colony morphology. They isolated two genes PEP1 and Op4, 
which are responsible for this morphological shift and these genes are isolated from the 
HIV infected patients. 
Cannon  RD,  Holmes  AR,  Mason  AB  et  al (1995)22 Candida  albicans  is 
frequently  isolated  from the  human mouth,  yet  few carriers  develop clinical  signs  of 
candidiasis. Oral candidiasis presents clinically in many forms. This reflects the ability of 
the yeast to colonize different oral surfaces and the variety of factors, which predispose 
the host to candida colonization and subsequent infection. Colonization of the oral cavity 
appears to be facilitated by several specific adherence interactions between C. albicans 
and oral surfaces, which enable the yeast to resist host clearance mechanisms. 
Monteil R and Madinier I  et al(1997)88  observed that C.albicans and C.krusei 
are the common candidal species isolated from HIV negative patients.  
Sweet SP (1997)123 stated that candida is a harmless commensal of oral cavity. 
They are virulent in patients whose immune status is low as in case of HIV infection. 
Pathogenecity  depends  on  the  hyphal  formation,  thigmotrophism,  protease  secretion, 
adherence and phenotypic switching.
Masur H (1999)85 the  most  common oppurtiunistic  infection  in  HIV infected 
patients is oral candidiasis, which can be used to assses the immune status of the patients. 
It is usually treated using cotrimazole and it shows various degrees of resistance. 
Bartie KL, Williams DW, Wilson MJ et al (2000)6 They studied the ability of 
candida albicans isolates to invade an in vitro oral tissue model and they correlated it 
with the infection origin particularly to hyperplastic  candidiasis  (CHC). Reconstituted 
human oral epithelium was infected with C. albicans isolated from normal oral mucosa, 
CHC, non-CHC oral candidiasis and squamous cell carcinoma (SCC; n ¼ 4). Differential 
patterns of invasion were evident and, whilst consistent for a given isolate, did not relate 
to the infection origin of the isolate. Two principal patterns of invasion were evident and 
described as either a ‘localised’ or a ‘uniform’ distribution of invading hyphae. Several 
isolates also exhibited superficial infection with limited hyphal invasion. In conclusion, 
the use of the in vitro tissue model allowed the assessment of the invasive capabilities of 
isolates of C. albicans. However, the apparent differences in invasive characteristics did 
not appear to be related to the clinical origin of isolates.
Krautgarner WD, Hanning M, Weitgasser R et al (2001)72  stated that candida 
attaches to the epithelium or to any keratinized structure in the body by two ways either 
with  fimbria  or  gets  attached  superficially.  Fimbria  mediated  adhesion  enables 
colonization of the epithelial surface and by invasion of the superficial epithelial cells via 
hyphae.
Maartens G (2002)79  said that various opportunistic infections  associated with 
HIV infections in sub-Saharan Africa differ markedly in their incidence from those in 
industrialized  countries.  Tuberculosis,  microsporidiosis,  pneumocystis  carinii  are  the 
commonest cause of morbidity and mortality.
CANDIDA IN HIV PEDIATRIC PATIENTS AND TREATMENT:
Fungal infections in HIV infected individuals are associated with advancement of 
disease.  In pediatric HIV infections,  symptomatic  children have a significantly highly 
incidence  of  clinical  candidiasis  and  persistent  drug  resistant  candidiasis  than  do 
asymptomatic HIV infected children103. Candida is a harmless commensal of oral cavity 
they are virulent in patients whose immune status is low as in case of HIV infection. 
Pathogenicity  depends  on  the  hyphal  formation,  thigmotrpism,  protease  secretion, 
adherence and phenotypic switching78. When the sign and symptoms are atypical, clinical 
diagnosis is verified by microscopic examination and culture118. The yeast identification 
depends on the physician; the timely identification of the organisms by a laboratory can 
aid  in  making  the  correct  diagnosis69.  The  usual  species  isolated  from HIV pediatric 
patients are Candida albicans, Candida glabrata, Candida tropicalis, Candida parapsilosis 
and Candida krusei93.  
Viscoli C, Castagnola E, Fioredda F et al(1991)133 stated that fluconazole, a new 
triazole derivative,  was evaluated in a pilot study of 34 episodes of candidiasis in 24 
children.  Clinical  and  microbiological  success  was  achieved  in  30  of  34  cases. 
Fluconazole might represent an effective alternative to amphotericin B in the treatment of 
candidiasis in children. Comparative trials are necessary to assess optimal dosages and 
efficacy.
Deborah  G  (1994)50 Oral  candidiasis  is  a  pathognomonic  sign  of 
immunocompromised  patients.  It  occurs  in  two  forms  in  oral  cavity  as  the 
pseudomembranous and erythematous form. Preferred treatment for oral candidiasis is 
cotrmoxiazole, candida isolated from HIV positive patients develop resistance soon. 
Kolokotronis A, Kioses V, Antoniades D, Mandraveli K (1994)69 They relate 
the relationship between oral candidiasis and hairy leukoplakia, circulating CD4 cells and 
serum anti p24 antibodies in 43 HIV positive patients. They found that these two lesions 
occur when the immune status of the patient is low and absence of antip24 antibodies 
influenced by low CD43.
Pfaller M A, Houston A, Coffmann S (1996)100 CHROMagar Candida is a new 
differential culture medium that allows selective isolation of yeasts and simultaneously 
identifies colonies of Candida albicans, C. tropicalis, and C. krusei. They evaluated the 
use  of  this  medium  with  316  yeast  isolates  including  247  isolated  directly  on 
CHROMagar from clinical material. A total of 43 of the 234 positive cultures contained 
mixtures of yeast species. Twenty (47%) of these mixed cultures were detected only on 
CHROMagar.  CHROMagar  is  extremely  useful  in  making  a  rapid  presumptive 
identification of common yeast species. This capability plus the ability to detect mixed 
cultures  of  Candida  spp.  promises  to  improve  and  streamline  the  work  flow  in  the 
mycology and clinical microbiology laboratory.
Hick MJ, Carter AB, Rossman SN et al(1998)54 determined the prevalence of 
fungal organisms in 27 HIV infected pediatric patients and  correlated it with the severity 
of immunosuppression state. They found that the amount of fungal organisms isolated 
from severely immunosuppressed patients were more than the other two groups.
Velegraiki  A,  Nicolatous  O,  heodoridou  M  et  al (1999)129 screened  4  HIV 
positive  pediatric  patients  who  had  linear  gingival  erythema.  They  could  to  isolate 
C.dubliniensis from 3 patients. They concluded that C.dubliniensis could be the cause for 
linear gingival erythema seen in these patients and could be a variant of erythematous 
candidiasis.
Pelletier R, Peter J, Antin C et al(2000)98 Oropharyngeal candidiasis (OPC) is a 
common  opportunistic  infection  in  human  immunodeficiency  virus  (HIV)-infected 
patients and other immunocompromised hosts. Cotrimazole troches are widely used in 
the treatment of mucosal candidiasis. The authors investigated the potential emergence of 
resistance to cotrimazole in a prospectively monitored HIV-infected pediatric population 
receiving this azole.  They compared MICs in macrodilution and microdilution assays. 
They further analyzed the correlation between these in vitro findings and the clinical 
response to antifungal therapy in 87 HIV-infected children. They conclude that resistance 
to cotrimazole develops in isolates of C. albicans from HIV-infected children, that cross-
resistance to other azoles may develop concomitantly, and that this resistance correlates 
with refractory mucosal candidiasis.
Reichart  Pa,  Samarnayaka LP,  Philipsen HP  et  al(2000)111 in  there studies 
stated that since erythematous candidiasis  posses only blastospores they are difficult to 
grow in laboratory conditions.
Nailum ER and Cittukr FG (2001)90 oral candidiasis is an early sign of illness 
or disease progression in HIV/AIDS and other immunocompromised states. Emergence 
of  new  candida  species,  drug  resistance  and  immature  immune  systems  add  to  the 
complexity of this condition, especially in children. Candida species accounts for 40% of 
normal  oral  flora.  Peseudomembranous  candidasis,  erythematous  candidiasis  and 
hyperplastic candidiasis are the common candidal carriage seen in HIV infected patients. 
Linear gingival erythema is considered to be one of the type of candidiasis.
Campisi G, Pizzo G, Milici ME et al(2002)20 assessed the candidal carriage rate 
in HIV infected patients and correlated with the CD4 cell count. Carriage rate was 61.9% 
and 29.3% in HIV positive individual and there was a significant correlation between the 
candidal carriage rate and the CD4 count.
Priscilla  DL,  Milan  EP,  Martinez  R  et  al(2002)104 the  authors  studied  the 
prevelance  of  candida  in  130 positive  patients,  used chromagar  to  identify  them and 
found that candida albicans was the common species to be isolated.
Starr JR and White TC (2002)120 Little is known about carriage of  Candida 
albicans, the predominant pathogenic yeast in oral infection, in children. They cultured 
buccal mucosal and gingival swabs from 150 normal Portuguese children to investigate 
the prevalence of  C. albicans  at baseline (before dental treatment), post-treatment, and 
12, 24, and 36months post-baseline. The children, aged 8 to 11years at baseline, had no 
systemic disease or clinical symptoms of oral candidiasis and there was decrease in the 
amount of candida before and after treatment.
Vargas  KG and Joly  S  (2002)128 Candida  samples  were  taken  from 54 HIV 
positive  patients  and  studied  the  yeast  carriage,  intensity  of  carriage  and  genotypes 
overtime. They found the intensity of carriage was significantly increased in symptomatic 
positive patients than in the negative patients. They isolated candida albicans and  noted 
that there was a change in the species of candida with elapse of time. They concluded that 
commensal  strain  colonizing  in  HIV positive  patient  can  undergo alterations  prior  to 
producing an episode of thrush.
Bosa VL, Birman EG, Cury AE et al(2003)15 studied oral fungal microbiota in 
30 HIV infected pediatric patients and compared them with the HIV negative patients 
using  sugar  assimilation  test,  germ  tube  test,  carbon  and  nitrogen  assimilation  test. 
C.albicans  and C.parpsilosis,  C.tropicalis  were the common species  isolated  from the 
HIV positive patients and C.albicans, C.guilliermondii were the common species isolated 
from the HIV negative pediatric group.
Kim JO, Garofalo L,  Shelly  DB  et  al(2003)66 isolated  Candidia  dubliniensis 
from  14  HIV  positive  patients  out  of  205  samples  using  API  system.  The  candida 
dubliniensis is a recently described specie that share many phenotypic and morphological 
features with Candida albicans.
Reichart  PA  (2003)110 stated  that  oral  candidiasis  (OC)  is  a  frequent  oral 
manifestation  of  HIV  infection  and  is  a  marker  for  disease  and  occurs  as 
pseudomembranous, erythematous or rarely hyperplastic variant; angular cheilitis is also 
seen. Candida albicans is frequently isolated but other species such as C. krusei and C. 
dublienensis  are  emerging.  Linear  gingival  erythema,  necrotizing  ulcerative  gingivitis 
and necrotizing  ulcerative  periodontitis  have been described in HIV-infected  patients. 
AIDS-associated Kaposi’s sarcoma (KS) predominantly occurs on the palate, the gingiva 
and the dorsum of the tongue. Histopathologically, oral KS is identical to classical KS. 
Oral KS has been treated surgically, using laser, radiotherapy and intralesional injections 
with  chemo-  and  immunotherapy.  After  introduction  of  highly  active  antiretroviral 
therapy (HAART) oral  manifestations,  such  as  OC, gingivo-periodontitis  and  KS are 
rarely seen.
Portela MB, Souza IPR, Costa EB et al (2004)103 they isolated candida species 
from 52 HIV positive pediatric patients from the subgingival area using CHROMagar. 
Candia albicans was the common species of Candida isolated. Candida glabrata, Candida 
tropicalis, Candida dubliniensis were the other common species isolated.
Salobrena AC, Cepeda LG, Laura C et al (2004)116 investigated the temporal 
changes in the prevalence of oral candidiasis and they found that oral candidiasis was 
prevalent  in  this  study group.  No significant  variations  in  incidence  were noted after 
HAART theapy.  They found that candidiasis  was the common fungal disease in HIV 
patients and they do not decrease significantly after HAART.
Villar CC, Kashleva H, Bagtzoglous DA et al(2004)132  candida albicans with 
the  true  hypha  can  attach  with  the  normal  or  injured  epithelium.  By stimulating  the 
release  of  cytokines  they  cause  injury  to  the  epithelium.  They  conclude  saying  that 
candida with true hypha is responsible for causing clinical lesion.
Hung  C,  Yang  Y,  Lauderdale  TL  et  al (2005)58 explained  the  Candidal  
colonization in HIV infected outpatients in Taiwan. The authors conducted a prospective 
cohort  study of  Candida  colonization  and  its  risk  factors.  50% of  the  patients  were 
colonized with  Candida  species.  They found that  antibiotic  treatment  and lower CD4 
counts (<200 cells/mm3) increased the rate of oropharyngeal candidiasis in HIV-infected 
patients,  while  antiretroviral  therapy  protected  patients  from  the  development  of 
candidiasis.
TECHNIQUES  FOR  ISOLATION  AND  IDENTIFICATION  OF  CANDIDA 
SPECIES:
There  are  a  variety  of  methods  available  for  identifying  yeast  from  clinical 
specimens.  The  germ  tube  morphology  studies  and  carbohydrate  utilization  and 
commercially available methods eg. CHROMagar, API 20, Uni-yeast  Tek are used to 
identify  the  yeast  morphology9.  Enzymatic  and  fluorogenic  test  are  conventional 
methods.  These  systems  are  commercial  systems,  which  give  quick  results64.  Each 
method has its advantages and limitations and frequently more than one method may be 
required to identify an organism to the species level.
Katsura Y and Uesaka I  (1974)64 estimated  the  severity  of  clinical  candidal 
lesion by estimating the free dispersed germ tube in the serum. They found that more the 
density of germ tube in the serum more will be the severity of the clinical lesion. This test 
is useful in estimating the seropositivity of deep seated candidiasis.
Fleming WH, Hopkins JM, Land GA (1977)40 used new medium named as corn 
meal agar that provides rapid presumptive identification of Candida albicans C. albicans 
is  differentiated  from  other  yeasts  by  the  sequential  production  of  germ  tubes  and 
chlamydospores.  In  a  comparison  with  cornmeal  agar  control  plates,  there  was  an 
increase  of  chlamydospore-forming strains  of  C.  albicans  and a  decrease  in  the time 
required for chlamydospore formation. This system helps to identify different candidal 
species. 
Berardinelli  S  and  Opheim  DJ  (1985)11  used  a  new  germ  tube  induction 
medium, composed of three parts Rabbit Coagulase Plasma with EDTA and two parts 
Tryp-Soy broth  and this  was  effective  for  the  presumptive  identification  of  Candida 
albicas.  This medium was safer  to use,  more  accurate,  and less expensive than other 
commercial germ tube induction media. This medium helps to identify Candida albicans.
Fung JC, Donta ST, Tilton RC (1986)42 Eighty-three serum specimens from 24 
patients  infected  with  Candida  albicans  were  with  the  Candida  Detection  System 
(CAND-TEC). The medical records of each patient were reviewed for clinical evidence 
of  Candida  colonization  or  disease.  CAND-TEC  showed  high  titer  in  patients  with 
disseminated candidiasis. This technique appears to be a useful, rapid, and noninvasive 
means of laboratory diagnosis of systemic candidiasis.
Perry JL, Miller GR, Carr DL (1990)99 isolated a total of 706 yeast strains and 
isolated were evaluated in parallel by the Candida albicans screen test and germ tube in 
comparison  with  the  API20C  yeast  identification  system.  Germ  tube  was  correctly 
identified  in  419  samples.  Germ  tube  negative  was  seen  in  Candida  tropicalis  and 
Candida parapsilosis. Sensitivity and specificity of both the systems is 98%.
Odds FC and Benaerts R (1994)93 used CHROMagar candida which is a novel, 
differential  culture  medium that  is  claimed to  facilitate  the isolation and presumptive 
identifications of candidal species. Out of 726 samples, which were incubated for 48hrs 
in 37degree centigrade. C.tropicalis produced blue colonies on the agar plate, C.krusei 
produced pink colonies, C.albicans produced green colonies. The major disadvantage of 
this medium is that it can identify only few variants of candidal species.
Beighton  D,  Ludford  R,  Clark  DT  et al (1995)10 used  a  new  differential 
medium,  CHROMagar  Candida,  for  the isolation  of clinically  important  yeasts.  They 
wanted to determine its usefulness in facilitating the study of oral yeasts. They recovery 
of yeasts on the medium was not significantly different from the recovery on Sabouraud 
dextrose agar. Candida (Torulopsis) glabrata, Candida parapsilosis, Candida magnoliae, 
Candida lusitaniae, Candida famata, Candida kefir, and Saccharomyces cerevisiae were 
readily  distinguished  from  C.  albicans  and  C.  tropicalis  isolates.  One  of  the  major 
disadvantage is that number of species identified is very less and it is very difficult to 
differenciate  Candida albicans  from Candida dubliniensis.  But still  it  is  a very useful 
medium for the study of yeasts associated with dental diseases.
Kirkpatrick WR, Revankar SG, Mcatee RK et al (1995)67  stated that Candida 
dubliniensis has phenotypic characters similar to that of Candida albicans. The authors 
screen 63 HIV positive patients for Candida dubliniensis and they used chrom agar. They 
could isolate Candida dubliniensis in 3 patients.
Crist  AE, Johnson LM and Burke PJ (1996)28 The  Microbial  Identification 
System  was  evaluated  for  the  identification  of  550  clinically  isolated  yeasts.  The 
organisms evaluated were fresh clinical isolates identified by methods routinely used in 
our laboratory (API 20C and conventional methods) and included Candida albicans (n 5 
294),  C. glabrata  (n  5 145),  C. tropicalis  (n  5 58),  C. parapsilosis  (n  5 33), and other 
yeasts (n 5 20). Of the 550 isolates tested, 374 (68.0%) were correctly identified to the 
species  level,  with 87 (15.8%) being incorrectly  identified  and 89 (16.2%) giving no 
identification.  The  most  frequently  misidentified  yeast  was  C.  glabrata,  which  was 
identified as S. cerevisiae 32.4% of the time. On the basis of these results, the MIS, with 
its current database, does not appear suitable for the routine identification of clinically 
important yeasts.
Heelan  JS,  Siliezar  D,  and  Coon  K  (1996)52 observed  that  the  germ  tube 
production is a method for the presumptive identification of Candida albicans has been 
in  use  for  many  years.  Methods  have  recently  been  developed  for  detecting  the 
production of the enzymes L-proline aminopeptidase and b-galactosaminidase by yeast 
isolates grown in culture. Both enzymes are produced by C. albicans; other yeasts may 
produce either L-proline aminopeptidase or b-galactosaminidase but not both enzymes. 
One hundred thirty-three clinical  yeast  isolates,  including 55  C. albicans, 27  Candida 
tropicalis, 22 Torulopsis (Candida) glabrata, and 29 other yeast isolates were tested by 
the germ tube production method and three tests for enzyme production, with the API 
20C method used as a “gold standard.” All three enzymatic methods evaluated provided 
more objective and rapid nonmicroscopic alternatives to the germ tube test and may be 
used to accurately distinguish C. albicans from other yeasts
Pfaller M A, Houston A, Coffmann S (1996)100 used CHROMagar Candida  a 
new  differential  culture  medium  that  allows  selective  isolation  of  yeasts  and 
simultaneously identifies colonies of Candida albicans, C. tropicalis, and C. krusei. They 
evaluated the use of this medium with 316 yeast isolates including 247 isolated directly 
on CHROMagar from clinical material.  Over 95% of stock and clinical isolates of  C. 
albicans,  C. tropicalis,  and  C. krusei  were correctly identified on the basis of colony 
morphology and pigmentation on CHROMagar. Additionally, CHROMagar also allowed 
the  identification  of  C.  (Torulopsis)  glabrata  at  a  similar  level  of  accuracy.  This 
capability  plus  the  ability  to  detect  mixed  cultures  of  Candida  species  promises  to 
improve  and  streamline  the  work  flow  in  the  mycology  and  clinical  microbiology 
laboratory.
Campbell CK, Davey KG, Holmen AD et al(1999)19 compared the efficiency of 
commercial yeast identification system (API system) with the conventional system for 
145 candidal samples. They found that false positive results were more in commercial 
system   than the conventional system.
Gales C, Pfaller A, Houston AK, Joly S et al(1999)43  Tried to Identifiy Candida 
dubliniensis based on Temperature and Utilization of Xylose and a-Methyl-D-Glucoside 
as  determined  with  the  API  20C  AUX  and  Vitek  YBC  Systems.  To  have  a  better 
understanding of the role of Candida dubliniensis in clinical infections, it is essential that 
microbiology  laboratories  can  identify  this  species  rapidly  and  accurately  in  clinical 
specimens.  C. dubliniensis has been reported to lack the ability to utilize xylose (XYL) 
and a-methyl-D-glucoside (MDG) and to  grow poorly or  not  at  all  at  45°C, whereas 
Candida albicans  isolates utilize XYL and MDG and usually grow well at 45°C. they 
tested 66 isolates of  C. dubliniensis  and 100 isolates of  C. albicans  with both the API 
20C AUX and Vitek YBC systems to evaluate the ability of the XYL and MDG tests 
contained within each of these systems to distinguish between the two species. Clinical 
microbiology laboratories could use lack of growth at 45°C and a negative XYL test with 
either the API 20C AUX or Vitek yeast identification system to provide a presumptive 
identification of  C. dubliniensis. A negative MDG test result with either system would 
also be helpful but may misclassify C. albicans  as  C. dubliniensis, especially when the 
API 20C AUX system is used.
Koehler AP, Chu K, Elizabeth T, Houang S and Cheng AB (1999)68 cornmeal 
identified the candidal species by using the morphological features were as CHROMagar 
identified  them  with  the  help  of  different  colours  for  different  species.  For  the 
identification of Candida species corn meal agar, CHROMagar and API system can be 
used.
Pincus D H, Coleman D C, Pruitt W R et al(1999)101 These authors   tested the 
sensitivity between conventional techniques and the commercial available products for 
isolation of C.dubliniensis in 210 candidal samples. They found that the sensitivity of 
commercial  system (API  20C AUX,  ID32  C,  RapID Yeast  Plus,  VITEK  YBC,  and 
VITEK 2 ID-YST systems)  is  more  and rapid  than  the  conventional  system and the 
differentiation between the C.albicans and C.dubliniensis is good in commercial system 
than the conventional system.
Wadlin JK, Hanko G,  Stewart R  et  al(1999)134 Two-hundred and one yeast 
isolates were compared with three commercial systems RapID Yeast Plus System with 3 
commercial  system namely:   Innovative Diagnostic  Systems,  Norcross, Ga.; API 20C 
Aux;  bioMerieux-Vitek,  Hazelwood,  Mo.;  and  Vitek  Yeast  Biochemical  Card,  bio-
Merieux-Vitek against an auxinographic and microscopic morphologic reference method 
for the ability to identify yeasts commonly isolated in clinical microbiology laboratory. 
The RapID Yeast Plus System was significantly better than either API 20C Aux (193 
versus 167 correct identifications) or the Vitek Yeast Biochemical Card (193 versus 173 
correct identifications; P 5 0.003) for obtaining correct identifications to the species level 
without additional testing. There was no significant difference between results obtained 
with API 20C Aux and the Vitek Yeast Biochemical Card system. The API 20C Aux 
system did not correctly identify any of the  Candida krusei  isolates (n  5 23) without 
supplemental testing and accounted for the major differences between the API 20C Aux 
and RapID Yeast Plus systems. Overall, the RapID Yeast Plus System was easy to use 
and is a good system for the routine identification of clinically relevant yeasts.
Brown DM, Rizk MJ, Falkler Wa et al(2000)18  They used immune system and 
suppressed cellular immunity in children HIV infection to provide disease progression. 
They isolated candida in 47 patients using rinse technique. CHROMagar, ATCC 49256, 
sugar  assimilation  test  were  used  to  identify  the  Candida  species.  They  found  that 
Candida glabrata, is the common species identified. Candida dubliniensis were isolated in 
3 patients.
Hidalgo HF, Orenga S, Lebeau B et al(2001)56 used Candida ID system, a new 
chromogenic  medium  for  the  identification  of  Candida  albicans  (blue  colonies)  and 
preliminary identification into a group of four species (pink colonies). They compared it 
with  Albicans  ID2  and  Sabouraud  gentamycin  chloramphenicol.  Out  of  446  fungal 
strains, Candida ID allowed the isolation of more species than Albicans ID 2 (95.5% 
versus 91.2%).
Kim  JO,  Garofalo  L,  Blecker  DS  et  al(2003)66   They  studied  the  candida 
dubliniensis retrospectively from the samples that are previously identified as Candidia 
abicans. They studied about 183 samples and isolated this species in 5 of the patients but 
there  was  no significant  clinical  relevance.  They concluded that  further  investigation 
might help to find the relevance of these species in pediatric group.
Materials & Methods
STUDY DESIGN: Prospective study, 150 consecutive HIV seropositive patients over a 
period of one year were enrolled by using convenience sampling technique.
STUDY  SUBJECTS: HIV  seropositive  pediatric  patients  from  Government  TB 
sanatorium, Tambaram, Government  Institute  of Children Health,  Egmore,  YRG Care 
VHS, Taramani and Ragas Dental Collage and Hospital, Uthandi, constituted the study 
group.150  patients  between  6  months  to  15  years  of  age  who  were  confirmed  HIV 
seropositive  either  by  ELISA /  Western  blot  /  Tridot,  tests  were  included.  Informed 
verbal  consent  was  taken  from  the  patient  /  guardian  for  clinical  examination, 
photography and for collecting salivary samples. All the clinical details were noted in a 
preformatted case sheet. Systemic lesions were diagnosed based on the clinical diagnosis 
given by the pediatrician of the respective hospital. All oral lesions were diagnosed based 
on the diagnostic criteria formulated by EC Clearing House (Annexure III)
SAMPLE COLLECTION: Salivary samples for candida evaluation were collected from 
the  oral  cavity  from both  symptomatic  and asymptomatic  HIV seropositive  pediatric 
patients using swab technique (Samaranayake swab technique) 
PROCEDURE: Step 1:  Sterile disposable cotton swab was used to collect samples. In 
symptomatic patients the sample was collected from the lesional area. In asymptomatic 
patients the sample was collected from the dorsum of the tongue.
Step 2:  The collected sample was inoculated in the Sabourauds Dextrose Agar (SDA) 
and incubated at 37 0C for 48 hours. 
Step  3:  The  morphology  of  the  colonies  and  the  Colony  Forming  Unit  (CFU)  are 
determined. 
Step  4:   Germ-tube  test  was  performed  to  identify  the  pseudohypha  forms,  which 
indicates that the yeast formed is candida albicans. 
Step 5:  The colonies are selected randomly from the Sabouraud Dextrose Agar plate and 
inoculated in the CHROMagar and incubated at 37  0C for 48 hours. The color of the 
colonies was noted.
Step 6:  Species that could not be identified by CHROMagar were subjected to cornmeal 
test. In this test, the samples were incubated at 37 0C for 48 hours. The morphology of the 
species was studied under light microscope.
MATERIALS:
SAMPLE COLLECTION:
1. Sterilized disposable cotton swab.
GERM TUBE TEST AND PREPARATION OF REAGENTS:
2. Disposable Petri dish 15ml size 
3. Conical flask 300ml
4. Distilled water 5liters
5. Chloramphenicol capsules 
6. Bunsen burner
7. Autoclave 
8. Physical balance
9. Disposable 15ml vials
10. Human serum 10 ml
11. Microscopic glass slide 
12. Cover slip
13. Light microscope
14. Petri dish 15ml 
15. Bacterial loop
16. Conical flask 300ml
REAGENTS: 
1. Sabourauds Dextrose Agar (SDA 15 grams)
2. CHROMagar Candida
3. Cornmeal Agar 
METHODS:
Specimen Collection:
     All  the  oral  candidial  samples  were  collected  from seropositive  patients  using 
disposable cotton swabs. (Figure 24)
SDA agar composition and preparation:
    Mycological peptone      _     10gm / L
    Dextrose                         _     40gm / L
    Agar                               _     15gm / L
 65 gm of SDA agar was suspended in 1000 ml of distilled water and heated to 
boiling  to  dissolve  the  medium  completely.  The  medium  was  sterilized  by 
autoclaving at 15 Ibs pressure, 121  0C for 15 minutes, then poured into sterile 
Petri dishes. 
 After 48 hrs of incubation of sample streak on the medium at 370C, the positive 
cultures  showed  individual  colonies  that  were  cream /  pale  brown,  smooth  / 
glabrous, moist / membranous appearance. (Figure 25 & 26)
 Quantification of colonies was done by calculating the number of colony forming 
units per ml (CFUs).
 These colonies were smeared on the slides, stained (Gram stain) and examined 
microscopically,  they  showed  characteristic  round  to  ovoid  yeast  forms  of 
candida. 
Germ-tube Test: 
 Representative colony were taken in an inoculation loop and dissolved in disposable 
plastic vials containing 2ml of human serum.
 This colony were incubated for 2 to 4 hours at 370C 
 The vial was shaked well, using disposable micropipettes 10microliters / ml of the 
solution was taken, one wet smear and one smear stained by Grams stain was made. 
(Figure 27 & 28)
 The smear was studied under microscope for presence of pseudohyphae and true 
hyphae 
Interpretation: 
Pseudohyphae:  filamentous,  cylindrical  outgrowth  from  the  yeast  cells  with  no 
constriction  present  at  the  base.  It  helps  to  differentiate  C.albicans  from the  other 
species of candida. 
CHROMagar Candida Composition and Preparation:
     Agar                                  _                 15 gm / L
    Peptone                               _                10.2 gm / L
    Chromogenic Mix               _                22gm   / L
 CHROMagar Candida powder was dissolved in distilled water in the proportion of 
47.7 gm/ L and heated to boiling to dissolve the medium completely. Large bubbles 
replace foam in about 2 minutes, and it should not be heated to more than 1000C. 
The media was cooled in water bath and poured into sterile Petri dishes.
 After 48 hours of incubation at 370C, presumptive identification of yeast isolates 
was done based on the color of the colonies. (Figure 29 & 30)
Interpretation:
• Green                       _      C. albicans
• Blue                         _      C. tropicalis
• Pink                         _      C. krusei
• White to pink           _      Other species.
Corn meal agar test:
Composition:
       Cornmeal               : 8gm
       Agar                       : 4gm
      Distilled water        : 200ml
      Tween 80[1%]       :  2gm
The above mentioned ingredients were mixed in a conical flask and autoclaved at 
121°C  for  15  minutes  and  poured  into  petri  plates.  Candida  species  were  identified 
according to the microscopic morphological features on the cornmeal Tween80 agar.
 An isolate from SDA was taken and inoculated by making 3 parallel cuts about half 
an inch apart at 45° into the cornmeal culture plate.
 The plate was incubated at 30°C for 48 hours. After 48 hours, heavy inoculum of 
yeast was streaked across the plate .A glass slide and cover slip were placed over it 
and examined under 10X at the edge of the cover slip. (Figure 31)
 Candida species were identified based on the microscopic morphological features.
 Interpretation:
Candida albicans: Chlamydospores present, abundant pseudohyphae, some true hyphae, 
clusters of blastospores. (Figure 33)
Candida  krusei:  Extensive  branched  pseudomycelium with  chain  of  elongated  cells 
giving  tree  like  appearances,  clusters  and  chains  of  blastospores  along  with 
pseudohyphae.
Candida tropicalis: No pseudohyphae, often radiating with clusters of blastoconida at 
center. (Figure 34)
Candida parapilosis:  Branched chains of elongated cells with clusters of blastospores 
along them, occasional giant cells. (Figure 32)

Statistical Analysis 
• Data  entry,  database  management  and  analysis  was  done  using  SPSS version 
10.0.5.
•  Chi-square  test  was  utilized  to  find  out  the  statistical  significant  difference 
between gender in age, religion, birth status, route of transmission, HIV status of 
father, mother and siblings, pattern of feeding, neonatal jaundice, past medication, 
present medication,  CD4 count, systemic lesions, oral lesions, clinical candidal 
type, candidal status and candidal species. 
• Clinical candidal type by age, candidal species by site and candidal species by 
gender difference also found by chi-square test. 
• Student t-test was applied to find out the mean CFU count difference between 
candidal status, gender and hemoglobin.
Results
150 pediatric patients were enrolled in this study. Of the 150 patients, 82 (55.7%) 
were males and 68 (45.3%) were females. 87 (58.0%) were between the age group of 
6-12 years  [45 (54.9%) males and 42 (61.8 %) females].  2 (1.3 %) patients were less 
then 12 months of age. (Table 1 Graph 1) 
Birth status of 148 patients was recorded. 9 (6.0%) had history of premature birth; 
139 (92.7%) had full term birth status. Birth status of 2 (1.3%) patients was not available 
as they were orphans. (Table 1 Graph 2) 
143  (95.3%)  patients  had  acquired  HIV infection  via  vertical  transmission.  6 
(4.0%) had a history of blood transfusion. For one (0.7%) patient who was an orphan the 
route of transmission was not available (Table 1, Graph 3)
HIV status of the parents were available for 150 patients. 117 (78%) children, the 
mother and the father were HIV positive. 6 (4.0%) children acquired HIV infection via 
blood transfusion and HIV status was not ascertained for the parents of 2 patients. The 
HIV status of the parents of 150 children were as follows: 118 (78.7%) fathers and 148 
(98.7%) mothers were positive. (Table 1, Graph 4)
Of  the  55  patients  siblings  for  whom  HIV  status  was  available,  15  (27.3%) 
siblings  tested negative  for  HIV infection  and 12 (21.8 %) tested positive.  (Table I,  
Graph 5)
Feeding pattern  the  children  was  recorded  in  128 (85.3%) patients.  81 (54%) 
children were breast fed, 12 (8%) were only bottle fed and 35 (23.3%) were both breast 
and bottle fed. (Table 1) 
Of  the150  children,  neonatal  jaundice  was  noted  in  32  (39%)  males  and  29 
(42.6%) females. (Table 1)
The past medical history revealed that 78 (52%) patients received ATT drugs and 
11 (7.3%) were given alternative medications (Siddha & Homeopathy medicine).  One 
(0.7%) patient had received ART treatment for 6months. (Table 2, Graph 6)
At the time of examination, 126 (84%) were taking antibiotics, 123(82%) were 
taking  multivitamins  and 76 patients  (50.7%) were on Iron supplements.  74 (72.5%) 
patients  were on ATT, 68 patients  (45.3%) were taking Antifungal therapy,  13(8.7%) 
patients  were  taking  Acyclovir  and  61  (40.7%)  patients  were  receiving ART  drugs. 
(Table 3, Graph 7)
Immune status of 150 patients showed that 37 (39.4%) were moderately immune 
suppressed, 34 (36.2%) had severe immune suppression and 23 (24.5%) had no immune 
suppression. (Table 4, Graph 8)
Systemic  lesions  were  observed  in  150  pediatric  patients.  Lymphadenopathy 
(Figure1) was the most common systemic lesion seen in 125 (83.3%) [69 (84.1%) males 
and 56 (82.4%) females]. Tuberculosis (TB) was the next most prevalent lesion seen in 
91 patients  (60.7%).  Of which pulmonary  tuberculosis  (PTB)  was the  most  common 
presentation. Of the 32 patients (21.3%) with PTB, there were 23 males (28.1%) and 9 
females (13.2%) (p=0.02). Out of 68 (45.4%) patients with cold abscess  (Figure 2 & 
Figure 3), 67 patients (44.7%) had cold abscess of the cervical group of lymph nodes [40 
(48.8%) were males and 27 (39.7%) were females] and only one female patient had cold 
abscess involving the axillary group of lymph node. Primary complex was seen in 38 
(25.3%) patients [males 18 (22%), females 20 (29.4%)], 73 patients (48.7%) had otitis 
media [males 40(48.8%), females 33(48.5%)], mumps in 37 patients (24.7%) [males 17 
(20.7%),  females  20  (29.4%)],  parotitis  (Figure  4) was  seen  in  28(18.7%)  patients 
[ males 17(20.7%), females 11(16.2%)] impetigo (Figure 5) was seen in 4(2.7%) patients 
and scabies  (Figure 6) was seen in 23 (15.3%)[males  14(17.1%), females  9(13.2%)]. 
Puritic eruptions  (Figure 12) was seen in 77 (51.3%) of patients [male 46(56.1%) and 
females 31(45.6%), Oropharyngeal Candidiasis  (Figure 7) was documented in only 4 
(5.9%)  female  patients  (p=  0.04).  Vaginal  Candidiasis  was  seen  in  4  (5.9%) female 
patients. Herpetic eruption (Figure 8), Herpes Zoster was observed in 6 (4%) of patients 
[males 2(2.4%) and females 4 (5.9%)] (Figure 9 & 10), warts and bronchitis had equal 
prevalence in both the genders [Male 1 (1.5%), Female 1 (1.5%)]. There was one case of 
molluscum contagiosum  (Figure 11) 1 (1.2%) and it was in a male patient. (Table 5,  
Graph 9) 
Oral lesions were noted in all the 150 pediatric patients. Oral candidiasis was the 
most  common  lesion  seen  in  97  patients  (64.7%)  [males  54  (65.4%),  females  43 
(63.2%)].  The most  prevalent  type  of candidiasis  was pseudomembranous candidiasis 
(PC)  (Figure  13  & 14) and  it  was  seen  in  85  (56.7%)  [males  44  (53.7%),  females 
41(60.3%)]. Angular cheilitis (AC) (Figure 17) was the next common candidial type seen 
in 36 patients (24%) [males 25(30.5%), females 11 (16.2%)] (p=0.054). erythematous 
candidiasis (EC) (Figure 15) was seen in 33 (22%) [males 16(19.5%), female 17(25%)], 
PC and EC was seen in 11(7.3%)[males 7 (8.5%), females 4 (5.9%)] and 2(1.3%) patients 
had   hyperplastic  candidiasis  (HC)  (Figure  16) [male  1(1.2%),  female  1(1.5%)]. 
Conventional gingivitis was the next common lesion noted in 14 patients (9.3%) [males 
6(7.3%), females 8 (11.8%)]. There were 12 (8.0%) cases of pigmentation (Figure 18 & 
19) [males 9(11%), females 3(4.4%)], 9(6%) cases of depapillation of the dorsum of the 
tongue (Figure 21 & 22) [males 8(8.5%), females 2 (2.9%)]. OHL (Figure 20) was seen 
in 8 patients (5.3%) [males 5(6.1%), females 3(4.4%)] and ulcers were seen in 8 patients 
(5.3%)  [males  4(4.9%),  females  4  (4.9%)].  Kaposi’s  sarcoma  was  seen  in  one  male 
patient. (Table 6, Graph 10)
The distribution of clinical candidal type observed in 87 (58%) patients between the 
age group of 6-12 are PC in 46 (52.9%) patients, EC in 20 patients (23%), HC in 1 patient 
(2.1%), AC in 19 (21.8%) patient and a combination of PC and EC in 10 (11.5%) patients. 
The  clinical  candidal  type  observed  in  61  (40.7%)  patients  between  the  age  group  of 
1-5years were, PC 37(60.7%) patients, EC 12(19.7%) patients, HC 1(1.6%) patients, AC in 
16 (26.2%) of patients and PC and EC was seen in 1 (1.6%). Only 2 (1.6%) patients in our 
study were less than 12 months of age and the clinical variant of candidal type observed in 
this age group was AC  in one patient (50%) and PC and EC in one patient (50%). (Table 7 
&Graph 11)
Out  of  150  patients,  candida  samples  were  collected  from  122  patients  who 
fulfilled the inclusion criteria.  Of the 122, 66(54%) were males and 56 (45.9%) were 
females. 
Out of 122 patients for whom the candida samples were obtained, 36 (29.5%) were 
clinically  asymptomatic  for  candida  infections  and  86  (70.5%)  were  clinically 
symptomatic. (Table8, Graph 12) 
 The candidal species isolated from 122 patients were C.albicans, C.tropicalis and 
C.krusei  (Figure 29). C.albicans was isolated in 32 patients (26.2%) [males 17 (25.8%), 
females 15 (26.8%)]. C.tropicalis was isolated in 24 (19.7%) [males 11 (16.7%), females 
13 (23.2%)] C.krusei was identified in 5 (4.1%) patients[4 (6.1%) were male and 1 (1.8%) 
was a female]. Mixed colonies of C.albicans with C.krusei (Figure 30) were isolated from 
2 patients  (1.6%) [males  1(1.5%),  females  1  (1.8%).  C.albicans  with  C.tropicalis  were 
isolated in 8 patients (6.6%) [males 3(4.5%), females 5(8.9%)]. Mixed colonies of non-
specific species with C.albicans was isolated from 4(3.3%) patients [males 2(3%), females 
2(3.6%)] and along with C.tropicalis was seen in 2(1.6%) and both were male patients. 
Mixed  colonies  of  C.krusei  with  C.tropicalis  (Figure  30)  was  isolated  from 2  patients 
(1.6%) [male 1(1.5%), female 1(1.8%)] Non-specific species (Figure 30) were isolated in 8 
patients (6.6%) [male 5(7.6%), females 3(5.4%)]. (Table 9, Graph 13) . Cornmeal test was 
done for the 8 nonspecifice species isolated from CHROMagar.
Of the 36 (29.5%) asymptomatic patients, Candida samples for all of them were 
taken  from dorsum  of  the  tongue.  The  species  isolated  were  C.albicans  6  (16.7%), 
C.tropicalis 6(16.7%) and C.krusei 2 (5.6%). Mixed colonies of C.tropicalis with a non 
specific species was isolated from one (2.8%) patient. (Table 10 & 11, Graph14& 15) 
The mean Colony Forming Unit (CFU) in this group was 6.269 ± 3.06.
The clinical presentation of candidal infection in 86 (70.5%) symptomatic patients 
were as follows, 54 patients had PC on the dorsum of the tongue. The candidal species 
isolated  were  C.albicans  in  20  patients  (37%),  C.tropicalis  in  11  patients  (20.4%), 
C.krusei in 3 patients (5.6%) and non specific species in 7(13%) patients. 2 patients who 
had PC on the lateral surface of the tongue, the species isolated was C.albicans 2(100%). 
Out of 30 patients who had PC on the dorsum of the tongue and EC on the hard palate, 4 
patients had EC only on the hard palate. The candidal species isolated in these samples 
was C.albicans in one patient and C.tropicalis in other patients (50%). 26 patients who 
had both PC and EC the species isolated were C.albicans in 3(11.5%), C.tropicalis in 6 
patients (23.1%), mixed colonies of C.albicans with C.krusei in 2 patients (7.7%) and 
with C.tropicalis in 8 patients (30.8%), nonspecific species with C.albicans in 4 patients 
(15.4%)  and  with  C.tropicalis  in  1(3.8%) were  isolated.  2(7.7%)  patients  had  mixed 
colonies of C.krusei with C.tropicalis  (p=0.00). (Table 10 & 11, Graph 14& 15) The 
mean CFU in the symptomatic group was 16.06± 3.17.  
There was a statistical significant difference in the mean CFU count between the 
symptomatic and asymptomatic patients (p=0.00). (Table 12, Graph 16)
The mean CFU count of candida for the 122 patients was 14.70 ± 5.05 in females 
and 12.09 ± 5.30 in males (p= 0.076). (Table 13, Graph 17)
 The mean CFU for clinical candidal type were, HC (17.80 ± 2.26), PC (16.31 ± 
3.09), PC and EC was (16.05  ± 3.34). EC had the least mean CFU count of (14.62  ± 
3.12). (Table 14, Graph 18) 
The patients with severe immunosuppression had a mean CFU count of 4.81 x 103 
cfu/ml.  In patients  with no suppression the CFU count was 6.35 x 103 cfu/ml and in 
moderately suppressed immune patients the CFU count was 4.21 x 103 cfu/ml. (Table 15,  
Graphs19) 
In our study, patients with normal hemoglobin level had CFU count of 13.61  ± 
5.62 and in patient who are clinically anaemic the CFU count was 15.1 ± 3.57. (Table 16,  
Graph 20)
Tables & Graphs
Table 1: HIV infected pediatric patients - Demographic characteristics (n= 150)
Variables
Male
n=82
(%)
45.7%
Female
n=68
(%)
45.3%
p value
Total
n=150
(%)
Age             <12 months 1 1.2 1 1.5
                    1 – 5 years 36 43.9 25 36.8
                    6 – 12 years 45 54.9 42 61.8 0.675
2 1.3
61 40.7
87 58.0
Religion      Hindu 76 92.7 55 80.9
                    Christian 5 6.1 12 17.6
                    Muslim 1 1.2 1 1.5
0.083
131 87.3
17 11.3
2 1.3
Birth status  Full term 77 93.9 62 91.2
                      Premature 5 6.1 4 5.9
                      Not known - - 2 2.9 0.295
139 92.7
9 6.0
2 1.3
Route of transmission
                      Vertical 78 95.1 65 95.6
                      Blood 4 4.9 2 2.9
                      Unknown - - 1 1.5 0.459
143 95.3
6 4.0
1 0.7
HIV status of Father
                      Positive 61 87.1 56 94.9
                      Negative 5 7.1 1 1.7
                      Not tested 4 5.7 2 3.4
                                Total 70 100 59 100
0.269
118 78.7
6 4.7
6 4.7
129 100
HIV status of Mothers
                        Positive 81 98.8 67 98.5
                        Negative 1 1.2 1 1.5 0.703
148 98.7
2 1.3
HIV status of Siblings
                        Positive 5 17.2 7 26.9
                        Negative 9 31.0 6 23.1
                        Not tested 4 13.8 2 7.7 0.696
12 21.8
15 27.3
6 10.9
Pattern of Feeding
                         Bottle 6 7.3 6 8.8
                         Breast 45 54.9 36 52.9
                         Combination 19 23.2 16 23.5 0.988
12 8.0
81 54.0
35 23.3
Neonatal jaundice 32 39.0 29 42.6 0.739 61 40.7
Graph 1: HIV infected pediatric patients - Age and gender distribution
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Graph 2: HIV infected pediatric patients - Birth Status
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Graph 3: HIV infected pediatric patients - Route of Transmission
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Graph 4: HIV infected pediatric patients - HIV status of Parents
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Graph 5: HIV infected pediatric patients - HIV status of the siblings
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Table 2: HIV infected pediatric patients - Past medication (n=150)
Past medication
Male
n=82
(%)
Female
n=68
(%) p value
Total
n=150
(%)
Anti tuberculous treatment 40 48.8 38 55.9
ART - - 1 1.5
Others:  Antibiotics
                Not known
1 1.2 - -
32 39.0 27 39.7
Alternative medications
            Homeopathy
            Siddha
4 4.9 2 2.9
5 6.1 - -
0.229
78 52.0
1 0.7
1 0.7
59 39.3
6 4.0
5 3.3
** Since 6month before the date of examination 
Graph 6: HIV infected pediatric patients - Past medication
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Table 3: HIV infected pediatric patients - Present medication (n=150) 
Present medication
Male
n=82
(%)
Female
n=68
(%) P value
Total
n=150
(%)
Antibiotics 69 84.5 57 83.8 0.565 126 84.0
Multivitamin 64 78.0 59 86.8 0.203    123 82.0
Antifungal dugs 36 43.9 32 47.1 0.412 68 45.3
Iron supplement 41 50.0 35 51.5 0.494 76 50.7
Anti tuberculous treatment 38 69.1 36 76.6 0.505 74 72.5
Anti viral drugs (Acyclovir) 5 6.1 8 11.8 0.174 13 8.7
ART 32 39.0 29 42.6   0.388     61 40.7
**At the time of examination
Graph 7: HIV infected pediatric patients - Present medication
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Table 4: HIV infected pediatric patients - Immune status (n=150)
CD4 COUNT Male
n=82
(%) Female
n=68 
(%) P value Total
n=150 
(%)
CD4        No suppression 14 27.5 9 20.9
                Moderate 18 35.3 19 44.2
                Sever 19 37.3 15 34.9
0.634
23 24.5
37 39.4
34 36.2
Graph 8: HIV infected pediatric patients - Immune status
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Table 5: HIV infected pediatric patients - Prevalence of systemic lesions (n=150)
Systemic lesions Male
n=82
(%) Female
n=68 
(%) p value Total
n=150 
(%)
Lymphadenopathy 69 84.1 56 82.4 0.828 125 83.3
Tuberculosis (TB)
Pulmonary TB
Primary complex
Cold abscess 
            Cervical TB
            Axillary TB
50 61.0 41 60.3 1.000 91 60.7
23 28.1 9 13.2 0.02* 32 21.3
18 22.0 20 29.4 0.347 38 25.3
40
1
48.8
1.2
27
-
39.7
-
0.323
1.000
67
1
44.7
0.7
Measles 49 59.8 39 57.4 0.868 88 58.7
Otitis media 40 48.8 33 48.5 1.000 73 48.7
Puritic eruption 46 56.1 31 45.6 0.132 77 51.3
Upper respiratory tract 
infection
32 39.0 22 32.4 0.495 54 36.0
Mumps 17 20.7 20 29.4 0.256     37 24.7
Parotitis 17 20.7 11 16.2 0.532 28 18.7
Scabies 14 17.1 9 13.2 0.650 23 15.3
Pneumonia 10 12.2 7 10.3 0.799 17 11.3
Herpes Zoster 2 2.4 4 5.9 0.257 6 4
Vaginal candidiasis - - 4 5.9 0.04* 4 2.7
Impetigo 4 4.9 - - 0.127 4 2.7
Oral pharyngeal candidiasis - - 4 5.9 0.04* 4 2.7
Systemic candidiasis 1 1.2 1 1.5 1.000 2 1.3
Bronchitis 1 1.2 1 1.5 1.000 2 1.3
Herpetic eruption 1 1.2 1 1.5 1.000 2 1.3
Common wart 1 1.2       1   1.5 1.000 2 1.3
Molluscum Contagiosum 1 1.2 - - 1.000 1 0.7
Any systemic lesion 82 100 68 100 1.000 150 100
* p value  < 0.05 Statistically significant
Graph 9: HIV infected pediatric patients - Prevalence of systemic lesions
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Table 6: HIV infected pediatric patients - Prevalence of oral lesions  (n=150)
Oral lesions Male
n=82
(%) Female
n=68 
(%) p 
value
Total
n=150 
(%)
Oral candidiasis
    PC*
   EC*
   PC + EC*
   HC*                   
  AC*
54 65.4 43 63.2 0.864 97 64.7
44 53.7 41 60.3 0.508 85 56.7
16 19.5 17 25.0 0.436 33 22.0
7 8.5 4 5.9 0.755 11 7.3
1 1.2 1 1.5 1.000 2 1.3
25 30.5 11 16.2 0.054 36 24.0
Pigmentation 9 11 3 4.4 0.226 12 8.0
Others ( Depapillation )  8 8.5 2 2.9 0.11 9 6.0
Gingivitis 6 7.3 8 11.8 0.406 14 9.3
Oral hairy leukoplakia 5 6.1 3 4.4 0.73 8 5.3
Ulcer 4 4.9 4 4.9 1.000 8 5.3
Kaposi’s sarcoma 1 1.2 - - 1.0 2 1.3
Any oral lesion 82 100 68 100 1.000 150 100
*PC – Pseudomembraneous candidiasis    
  EC – Erythematous candidiasis
  HC – Hyperplastic candidiasis                 
 AC –  Angular chelitis
 PC + EC – Pseudomembraneous candidiaisis & Erythematous candidiasis
Graph 11: HIV infected pediatric patients - Prevalence of oral lesions 
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Table 7: HIV infected pediatric patients - Clinical candida type by age (n=150)
Age
Clinical Candidal Type <12 month 1-5 years 6-12 years Total
n % n % n % n % p value
PC 2 100 37 60.7 46 52.9 85 56.7 0.29
EC 1 50 12 19.7 20 23 33 22 0.56
HC 0 0 1 1.6 1 1.1 2 1.3 0.95
AC 1 50 16 26.2 19 21.8 36 24 0.56
PC & EC 0 0 1 1.6 10 11.5 11 7.3 0.71
OC 2 100 41 67.2 54 62.1 97 64.7 0.46
Graph 13: HIV infected pediatric patients - Clinical candida type by age 
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Isolation and speciation of oral candida in HIV infected pediatric patients (n=122)
Table 8: Isolation and speciation of oral candida - Clinical candida status by gender
Candidia Male
n=66
(%) Female
n=56
(%) P 
value
Total
n=122 
(%)
Asymptomatic 20 30.3 16 28.6
Symptomatic 46 69.7 40 71.4
0.497 36 29.5
86 70.5
Graph 14: Isolation and speciation of oral candida - clinical candida status by 
gender
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Table 9: Isolation and speciation of oral candida - Candida species by gender 
(n=122)
Species / Gender Male
n=66
(%) Female
n=56
(%) P 
value
Total
n=122 
(%)
C.albicans 17 25.8 15 26.8
C.tropicalis 11 16.7 13 23.2
C.krusei 4 6.1 1 1.8
C.albicans + krusei 1 1.5 1 1.8
C.albicans + tropicalis 3 4.5 5 8.9
Others + albicans 2 3.0 2 3.6
Others+ tropicalis 2 3.0 - -
C.krusei + C.tropicalis 1 1.5 1 1.8
No 20 30.3 15 26.8
Others 
(nonspecific species) 5 7.6 3 5.4
TOTAL 66 100 56 100
0.833
32 26.2
24 19.7
5 4.1
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8 6.6
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35 28.7
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122 100
Graph 15: Isolation and speciation of oral candida -  candida species by gender
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Table 10: Isolation and speciation of oral candida -  candida species by site (n=122)
SPECIES / SITE Dorsum + 
palate
Lateral 
tongue
Hard 
palate
Dorsum 
tongue
Total
n % n % n % n % n %
C.albicans 3 11.5 2 100 1 25.0 26 28.9 32 26.2
C.tropicalis 6 23.1 - - 1 25.0 17 18.9 24 19.7
C.krusei - - - - - - 5 5.6 5 4.1
C.albicans + krusei 2 7.7 - - - - - - 2 1.6
C.albicans + tropicalis 8 30.8 - -  - -  - -  8 6.6
Others + albicans 4 15.4 - - - - - - 4 3.3
Others+ tropicalis 1 3.8 - - - - 1 1.1 2 1.6
C.krusei + C.tropicalis 2 7.7 - - - - - - 2 1.6
No - - - - 2 50 33 36.7 35 28.7
Others 
(nonspecific species) - - - - -    -  8 8.9 8 6.6
TOTAL 26 100 2 100 4 100 90 100 12
2
100
P value : 0.00**
Graph 16: Isolation and speciation of oral candida - candida species by site 
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Table 11: Isolation and speciation of oral candida - Candida species on the dorsum 
of tongue in symptomatic and asymptomatic group (n=122)
Candida species Candidiasis
Asymptomatic                    symptomatic
n % n %
Total
C.albicans 6     16.7 20 37.0 26 28.9
C.tropicalis 6     16.7 11 20.4 17 18.9
C.krusei 2     5.6 3 5.6 5 5.6
Others + C.tropicalsis 1     2.8 - - 1 1.1
No 20     55.6 13 24.1 33 36.7
Others 
(nonspecific species) 1
    
 2.8 7 13.0 8 8.9
TOTAL 36      100 54 100 90 100
p value : 0.022
Graph 17: Isolation and speciation of oral candida- Candida species on the dorsum 
of tongue in symptomatic and asymptomatic group 
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Table 12: Isolation and speciation of oral candida - Mean CFU 
CANDIDIA CFU x103units/ml Std. deviation p value
Asymptomatic (n=26) 6.269 3.06
Symptomatic (n=82) 16.06 3.17 0.000**
**P value:  <0.01
Graph 18: Isolation and speciation of oral candida - Mean CFU 
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Table 13: Isolation and speciation of oral candida - Mean CFU count by gender 
Sex CFU x103units/ml Std. deviation p value
Male (n=60) 12.90 5.30
Female (n=48) 14.70 5.05 0.076
Graphs 19: Isolation and speciation of oral candida - Mean CFU count by gender 
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Table 14: Isolation and speciation of oral candida - Mean CFU by clinical candida 
type
Type / CFU n CFU x103units/ml Std. deviation p value
PC 40 16.31 3.09
EC 9 14.62 3.12
HC 2 17.80 2.26
PC &EC 31 16.05 3.34
Total 82 16.06 3.17
0.449
Graph 20: Isolation and speciation of oral candida- Mean CFU by clinical 
candida type
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Table 15: Isolation and speciation of oral candida - Mean CFU by immunological 
status (n=122)
CD4 n CFU p value
No suppression 17 6.35
Moderate suppression 25 4.21
Severe suppression 29 4.81
0.241
Graph 21: Isolation and speciation of oral candida - Mean CFU by immunological 
status
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Table 16: Isolation and speciation of oral candidiasis - Mean CFU by hemoglobin 
status (n=122)
 
Hemoglobin N Mean CFU Std. Deviation P value
Normal 60 13.61 5.62
Anemic* 45 15.1 3.57
0.15
* Hemoglobin level ≤ 9mg/dl
Graphs 22: Isolation and speciation of oral candida - Mean CFU by hemoglobin 
status
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Photographs 
Figure 1: Lymphadenopathy
Figure 2: Cold abscess

Figure 3: cold abscess
Figure 4: Parotid gland enlargement
Figure 5: Impetigo 
Figure 6: Scabies
Figure 7: Oropharyngeal candidiasis
Figure 8: Herpetic eruptions
Figure 9: Herpes zoster
Figure 10: Herpes zoster
Figure 11: Molluscum Contagiosum
Figure 12: Puritic Papillary Eruption
Figure 13: Pseudomembranous candidiasis
Figure 14: Pseudomembranous Candidiasis
Figure 15: Erythematous candidiasis
Figure 16: Hyperplastic Candidiasis
Figure 17: Angular Chelitis
Figure 18: Pigmentation
Figure 19: Pigmentation
Figure 20: Oral Hairy leukoplakia
Figure 21: Central depapillation of tongue
Figure 22: Complete depapillation of tongue
Figure 23 : Dental caries
Figure 25 : Candidal colonies on SDA agar
Figure 26:  Subculture of candida in SDA agar
Figure 27: Candidal hypha-methyl violet stain
Figure 28: Germ tube test – candidal Hypha x oil immersion
Figure 29: Candidal species – CHROMagar
Figure 30: Candidal species -  CHROMagar
Figure 30: Candidal species – CHROMagar
Figure 31: Candidal colonies on Cornmeal agar
Figure 32: Cornmeal agar- C. parapillosis 40x 
Figure 33: Cornmeal agar- C. albicans 10x 
Figure 34: Cornmeal agar- C. tropicalis 10x 
Discussion 
HIV infection and AIDS are spreading rapidly among the pediatric  population 
since the report of the first case in 198257. Over 20 million people have died from AIDS 
since the first  case was identified  in 1981.  Today,  about  37.8 million  people (range: 
34.6-42.3 million) are living with HIV; 2.1 million (range: 1.9-2.5 million) of them are 
children under the age of 15. More than 1,900 children worldwide are infected with HIV 
each  day.  In  2005 of  2.9 million  people  (range:  2.6-3.3 million)  who died of  AIDS, 
490,000 (range: 440,000-580,000) were children. This amounts to approximately 1,350 
AIDS deaths in children per day, worldwide. World wide 12 million children have lost 
one or both parents to AIDS. By 2010, this number is expected to rise to more than 18 
million.  In  the  developed countries  there  are  only  a  few hundred  or  a  few thousand 
orphans but in the developing countries there are millions and this difference is due to the 
accessibility  to  ART  in  the  developed  countries.  In  India  the  estimated  number  of 
children infected with HIV infection is 120,000138.
Oral lesions are common in adults with HIV infection and have diagnostic and 
prognostic significance109. Although oral manifestations of HIV infection in adults have 
been well  established,  little  is known about oral  lesions in children,  especially Indian 
children.
In this study we studied systemic and oral manifestations in 150 children infected 
with HIV. The male and female ration was 1.7:1. This is similar to the reports by Lucas 
SB et al 199676 in their study of 78 pediatric patients in Abidjan population and Matida 
LH et al 200486  in their study of 914 pediatric patients in Brazil.
In our study, though there was no significant difference in distribution of children 
in different age groups, more than 50% were in the 6-12 year age group. This finding was 
similar  to the reports of  Kozinetz CA et al 200171 from 62 patients  in Romania and 
Agarwal M et al 20012 on 821 patients in India, and observed that the prevalence of HIV 
infection in this cohort was more in children between the age group of 7-12 years. 
HIV can be transmitted perinatally from a mother to her new born infant (vertical 
transmission) in three ways: (1) transplacentally during pregnancy; (2) during delivery, as 
the  infant  passes  through the  birth  canal  (estimated  to  be  40% of  the  cases);  or  (3) 
postnatal,  during  breast  feeding.  Ninety  four  percent  of  pediatric  HIV infections  are 
acquired perinatally, and the vast majority are acquired during delivery45, 48. In developing 
countries majority of children are infected with HIV either in antepartum (20% before 
childbirth); intrapartum (40% during childbirth), or breastfeeding (40%) 138.  
.In our study the predominant mode of acquiring HIV infection was by vertical 
transmission during the time of  delivery and this  finding was consistent  with that  of 
Hermione EG et al  in 200253 who reported that 70% of their  patients  acquired HIV 
infection  through vertical  transmission.  Merchant  RH et  al  2001 87 reported  vertical 
transmission in 247 (86.99%) cases and stated that vertical transmission was the major 
mode of HIV infection seen in India.  
Breast feeding is the second major mode of vertical transmission seen among the 
pediatric group in the developing countries  13,  45  In our study 81 (54%) children were 
breast fed and the mean duration was 2.5years from the time of birth. It has been reported 
that  the overall  risk of transmission of HIV from mother  to child is  15-25% for non 
breast-feeding mother, and 25-45%, for breast-feeding mother53. In our study, also breast-
feeding may have contributed to a mode of vertical transmission. 
Infection  with HIV results  in  profound immunosuppression  rendering  the host 
susceptible to various infections and neoplasms91. In non - infected children the CD4 cell 
count is higher than in the adults, but declines over the first 6 years of life to approach 
adult levels, by the age of 6 years  45.  The disease progression in HIV infected child is 
rapid and fulminating since most of the immune system is still in the developing stage2.
Based on the immune categories, age of the children and clinical categories, CDC 
has classified the children with HIV infection, into three categories . In our study 25% 
were in category I (No suppression), 39.4% were in category 2 (moderate suppression) 
and 36.2% were in category 3 (severe immune suppression).
 Clinical features of HIV infection are common to both adults and children, but 
some are more  typical  and pronounced among the pediatric  population 45.   Failure  to 
thrive, which is associated with an abnormal growth rate, may affect as many as 50% 45 to 
95% 119, 75.  Tuberculosis2, 8,  75,  92 and generalized lymphadenopathy8,2,71,119are the common 
systemic lesions seen in pediatric children infected with HIV in the developing world. 
Other  conditions  more  commonly  found  among  children  are  lymphoid  interstitial 
pneumonia45,92 invasive  and  recurrent  bacterial  infections45,86,92,102,  pnemocystis  carinii 
pneumonia76,86,102, respiratory tract infection71,75,76, otitis media71, bacterial septicemias102, 
parotitis45,  CMV102,  meningitis86,  chronic  diarrhea2,8,  persistent  cough2,8,  severe 
malnutrition2,8,  generalized  dermatitis2,8,118,  disseminated  herpes  simplex92, 
splenomegaly118,  hepatomeglay2,8,71 and  neoplasms  namely  lymphoma45,92 and 
leiomyosarcoma45. 
In  this  study all  the 150 patients  had one or  more  systemic  lesions,  the most 
common lesion observed in our study was lymphadenopathy in 125 patients  (83.3%). 
Similar to reports by Spira R et al 1999119  (Rwanda) in  347 children,  Naidoo S et al 
200491 (South  Africa)  in  169 children  and  Kozinetz  et  al  in  200l70  (Brazil) in   73 
children, showed lymphadenopathy as the most common lesion in 91.1%, 92% and 51% 
respectively.
In our study 61% of the children presented with tuberculosis (TB) and this include 
both pulmonary tuberculosis (PTB, 21.3%), primary complex 25.3% and extra pulmonary 
tuberculosis (ETB 45.4%). Swaminathan S 2004122 (chennai), in his study of 87 patients 
reported disseminated TB in 34% and pulmonary TB in 37% of cases. Lodha R et al 
2000 75 (New Delhi), reported disseminated TB in 27.3% of patients in their study of 27 
HIV patients. Bavdekar SB et al 20058 (Mumbai) observed disseminated TB in 22.7% 
of cases out of 115 patients, Kozinetz et al in 200l71 (Romania) and Palme IB et al in 
200196 (Ethiopia)  reported  that  11.2%  of  children  in  their  study  had  pulmonary 
tuberculosis. In the study done by Jones DS et al in 199771 (New Jersey) and Chan SP 
et al in 1996 26 (New York), the prevalence of PTB was 21% and 55% respectively. In 
our study extra pulmonary variants of tuberculosis observed were cold abscess in 45.4% 
of  patients.  There  is  no  other  similar  report  to  our  knowledge  from the  developing 
countries, which has detailed the occurrence of variants of extra pulmonary TB. In our 
study we also observed that there was a significant difference in the occurrence of TB 
between gender. 
Measles was the next common systemic lesion in our study and it was seen in 
more than 50% of the children. Similar prevalence rate have been reported by Lucas SB 
et al 199676 (Abidjan)  in 19% of pediatric patients and was more common in children 
greater than 15 months of age in their study.
 Other opportunistic infections seen in our study were otitis media in 48.7% of 
cases, upper respiratory tract infection (URTI) in 36% of cases and mumps in 24.7% of 
cases, Kozinetz et al in 200l71(Romania) have reported otitis media in 97% of 762 HIV 
infected children.   
In  our  cohort  study  the  cutaneous  lesions  observed  were  scabies  (15.3%), 
impetigo  (2.7%)  and  pruritic  eruption  in  52.1%  of  cases.  Bavdekar  et  al  20058 
(Mumbai) in their study of 115 pediatric patients have reported generalized dermatitis 
which also included pruitic eruption and eczema in 83.3% of patients. There was only 
one case of molluscum contagiosum in our study and this entity was also reported by 
Faitz C et al 200036(Romania) in 3% of 173 pediatric patients and by Merchant RH et 
al 2001(India) 87  in 3 cases out of 285 patients in their study.
Parotid gland enlargement may be caused by infiltration of CD8 cells which are 
cytotoxic  to  HIV  infected  cells  and  have  the  ability  to  destroy  the  virus,  probably 
explaining the slower progression in children with such pathology45.  In our study we 
found 18.7% of patients had parotid gland enlargement. Parotid gland enlargement was 
also reported by  Dos LD et al 200030 and  Luciane RR etal 199877 in Brazil,  but the 
prevalence was 9% and 7.3% respectively. Other authors have also reported parotid gland 
enlargement in their study 36, 70, 71,106,126  
 Herpetic eruption of the perioral areas was observed in 2 patients (1.3%) in our 
study and this finding was similar to that reported by Dos LD et al 200030 ( Brazil)  in 
their study of 80 pediatric patients and  Romos F et al 1996107 (USA) in their study of 
492 pediatric patients. 
In our study, 4 (18.7%) children had perioral warts. Flatiz et al 200036 (Romania) 
observed oral warts in 2% of 172 pediatric patients in their study and one case has been 
reported by Magalhaes et al 200181(Brazil) in their study of 38 pediatric HIV infected 
patients. To our knowledge this is the first report from in India , which of oral warts in 
HIV infected pediatric patients.
 Systemic candidiasis was seen in 2 cases (1.3%). Oropharyngeal candidiasis and 
vaginal  candidiasis  were  seen  in  4  cases  each.  The  4  patients  with  oropharyngeal 
candidiasis developed dysphagia. Our clinical observation of dysphagia in patients with 
oropharyngeal candidiasis was consistent with that reported by  EiHachem et al 199832 
(Brazil) in their study of 85 HIV infected Brazilian children. 
Oral mucosal lesions are one of the earliest clinical indicators of HIV infection 
and  progression  in  children48. Presentations  of  orofacial  lesion  in  patients  with  HIV 
infection  are  strongly associated  with immune suppression 48.  The occurrence  of  oral 
lesions is probably geographically site-specific,  because the frequency of specific oral 
lesions differ regionally.48
In our study the most common oral lesion was oral candidiasis, seen in 64.7% of 
the  patients  and  this  finding  was  similar  to  the  reports  of  Romos  F  et  al  1996107 
(California). In their study of 495 patients, where they observed oral candidiasis in 67% 
of cases and  Naidoo S et al 200491  (South Africa) in their study of 169 patients who 
reported oral candidiasis in 63% of their cohort.  Lodha R et al 200075 (India) in their 
study  of  27  HIV  infected  children  observed  OC  in  36.4  %  of  cases  and  the  low 
prevalence of oral candidiasis in their study was due to small sample size.
 Of the variants of OC in our study PC was observed in 56.7% of children and this 
was the predominant clinical type of candidiasis. This finding was similar to the findings 
of  Naidoo S et al 200491(South Africa)  and  Romos F et al 1996107 (California)  who 
reported 50% and 47% of PC in their respective studies. Other authors have also reported 
oral candidiasis as the most common lesion in their studies 8,30, 47,55, 70, 71,75,77, 100,108,126.
 The prevalence of AC (24%) in our study was slightly higher compared to the 
studies reported by  Naidoo S 200491(South Africa), Luciane RR et al 199877 (Brazil) 
and Pongsiriwes et al 2003  102(Thailand)  and this was due to malnourishment which 
was prevalent in the lower socioeconomic status of our cohort.
EC was observed in 22% of our patients, and this finding was similar to reports of 
Naidoo S 200491(South Africa), who reported EC in 20% of their pediatric seropositive 
patients.  Luciane  RR  et  al  199877  (Brazil),  Pongsiriwes  et  al  2003  102(Thailand), 
Barash A et al  20005 (Roman) are few others who reported low prevalence  of EC 
compared to our study and this was due to smaller sample size in their study.
We observed HC in 2 cases and this  finding was similar  to that  of  Naidoo S 
200491 and Flanagan et al 200039 who also reported HC in their study group.
Combined lesions of PC and EC was observed in 7.3% of cases in our study and 
this finding was consistent with that of Flanagan et al 200044 (New Jersey).
Next  common  oral  lesion  in  our  study  group  was  conventional  gingivitis, 
observed in  9.3%, of  the  patients,  we did  not  come across  linear  gingival  erythema. 
Conventional  gingivitis  has  also  been  reported  by  Barash  A  et  al  20005(Roman), 
Luciane RR et al 199877  (Brazil), Gomez FJ et al 2000  47  (USA)   Schoen DN et al 
2000117 (USA) and Flaitz C et al 200036 Romania) and the prevalence is similar to that 
of our study. Howell RB 199657 (USA),Gelbier M et al 200044 (London) and Carvalho 
L et al 200530 (Brazil) not only reported a high prevalence of conventional gingivitis, but 
also found an association between conventional gingivitis and  immunosuppression.
In  our  study  we  observed  OHL  in  5.3%  of  patients.  Flaitz  C  et  al 
200036(Romania)  in  their  study  of  173  patients  have  reported  OHL in  2% of  their 
patients. Naidoo S 200491 (South Africa) reported OHL in 1% of 169 pediatric patients. 
Barash A et al 20005 (USA) and Kozinetz C et al 200070 (USA) have reported OHL in 
2% of their study group. Pongsiriwes et al 2003 102(Thailand) observed OHL in 22.5% 
of cases in their study. This high prevalence of OHL in their study was due to the fact 
that OHL is widely prevalent in Thailand, due to high prevalence of EB virus. 
Kaposi’s sarcoma is the most common neoplasm developing among HIV infected 
adults and is rare in children45. In our study we observed Kaposi’s sarcoma of the palate 
in one case. Kozinetz C et al 200171 (Brazil) had a similar observation. 
One of the unique finding in our study was the oral pigmentation present in 12 
patients (8%). Pigmentation was seen on the dorsal surface of tongue, hard palate and on 
the buccal mucosa. In our study, children who presented with oral pigmentation were on 
iron supplements. The existing anemic in these children could have been the contributing 
factor to oral pigmentation in these children.
 6% of patients had depapillation of the dorsum of tongue, and these lesion were 
positive for candida albicans. Flanagan et al 200039(New Jersy) observed similar lesion 
in 8% of pediatric patient cases in their study of 37 HIV infected pediatric patients. 
In our study we observed oral ulcers in 8 patients (5.3%) which were clinically 
suggestive of apthous ulcers and was seen predominantly on the buccal mucosa,  This 
finding was similar to the reports of Toro AD et al 1996127(New York) and Luciane RR 
et al 199877 (Brazil) who reported oral ulcers in 5% of their cases.   
Candida albicans is a normal commensal of the oral cavity. The normal candidal 
carriage rate in healthy adult ranges from 3% to 48% and in healthy children it is 45% to 
65% 88. Lowest candidal carriage rates are seen in neonates which is estimated to be 9% 
to 16%78.  
 In our study we attempted  to  isolate  and identify the candida species in 122 
children,  with  and  without  clinical  candidiasis  referred  to  as  symptomatic  and 
asymptomatic respectively. Of the 122 patients 86 (70.5%) patients, were found with a 
diagnosis with clinical candidiasis (symptomatic for candida) . Of these 86 symptomatic 
patients, we were unable to isolate candida from 13 patients. When we analyzed these 
results, we found that these 13 patients had a clinical diagnosis of EC, Reichart PA et al 
in 2000111 in their study explained that, in their experience, cases which presented as EC 
clinically when subjected to laboratory investigation did not show any growth on the 
primary  the  culture  medium.  This  could  be  due  to  the  fact  that  EC  possess  only 
blastopore, which is difficult to grow in the laboratory. 
In  our  study  there  were  36  patients  who  were  asymptomatic  for  candidiasis 
clinically. Bosco et al 200315 (Brazil) in their study of 30 HIV infected patient stated that 
there is an association between the level of immune suppression and candidiasis.  Hicks 
JM et al in 199854 (London)  in 27 HIV pediatric patients found that yeast and fungal 
organisms were isolated more from patients with severe immune suppression state. We 
were able to isolate candida in 16 patients and in 20 patients we could not demonstrate 
the growth.  The possible reason of this could be due to the fact that most of the patients, 
in whom candida could not be isolated, had high CD4 count.   
Candida  was  speciated  by  CHROMagar  technique93.  The  common  species 
isolated  were  C.albicans,  C.tropicalis,  C.krusei,  mixed  colonies  of  C.albicans  with 
C.krusei and C.albicans with C.tropicalis. Other species (which could not be typed with 
CHROM agar) and mixed colonies of other species with C.albicans & with C.tropicalis 
were  also  speciated.  In  our  study,  C.albicans  was  the  predominant  species  isolated, 
followed by C.tropicalis and this finding was consistent with that of Bosco VL et al in 
200315 (Brazil) who isolated C.albicans as predominant species in 23% patients. Mixed 
colonies of C.albicans with C.topicalis & C.krusie were the next prevalent combination 
of  candidal  species  isolated  in  our  study.  There  was  an  equal  prevalence  of  mixed 
colonies of other species with C.albicans and with C.tropicalis. 
8 cases of non specific species which was isolated by CHROMagar in our study 
were  identified  as  C.parapsilosis  in  two  cases,  mixed  colonies  of  C.tropicalis  with 
C.parapsilosis  in  6  samples  with  cornmeal  agar.  Bosco  VL  et  al  in  200315 (Brazil) 
isolated C.parapsilosis in 30 HIV positive pediatric patients using sugar assimilation test. 
Kim JO et al 200366 (Philadelphia) isolated C.dubliniensis from 205 patients using API 
20C  system,  this  finding  illustrates  that  CHROMagar  technique  is  not  sensitive  to 
subtype all candidal species10,93. 
Of the 90 children for whom the samples  were collected  from the dorsum of 
tongue,  hard  palate  and  the  lateral  surface  of  tongue.  C.albicans  was  the  most 
predominant species isolated in 29% of them and the next prevalent species isolated was 
C.tropicalis in 19.0% of the patients. 
In  our  study,  in  both  symptomatic  and  asymptomatic  HIV  positive  pediatric 
children the predominant species isolated was C.albicans and C.tropicalis. There was a 
significantly lower prevalence of candida in asymptomatic than in symptomatic patients.
CFU count of candida in asymptomatic HIV infected adult patients was estimated 
to be <4 x 103 units/ml and for symptomatic patients it is  >4 x 103 units/ml 111.  To our 
knowledge CFU count of candida is not established in HIV infected children.
 In our study the CFU count of candida was calculated for all  the samples as 
described by Samarnayaka et al 1990. In our study CFU count in asymptomatic patients 
was 6.3 x 103 CFU /ml and in symptomatic patients was 16.0 x 103 CFU /ml and there 
was a statistically significant difference in CFU count between the two groups. The CFU 
count in our pediatric population appears to be high when compared to the CFU count in 
adult  this  difference  may  be  due  to  the  immature  immune  system  seen  in  pediatric 
population.
Bosco et al 200315(Brazil) in 30 children observed that CFU count was high in 
severely  immunosupressed  patient  compared  to  children  with  lower  degree  of 
immunosuppression.  Though  we observed  a  difference  in  the  CFU count  of  candida 
between the children with varying degree of immunosupression, the difference was not 
statistically significant.
Summary & Conclusion
• A total  of  150 HIV seropositive pediatric  patients  were screened for  oral  and 
systemic lesions. Candidal samples were collected for 122 patients  using swab 
technique  and  CFU  was  estimated.  Candidal  species  were  isolated  by  using 
CHROMagar.
• Out of 150 patients, 82 (55.7%) were males and 68 (45.3%) were females and 
majority of them were between the age group of 6-12 years.
• 139 patients  (92.7%) had  full  term birth  status  and about  9(6%) patients  had 
history of premature birth status and for the rest of the patients birth status was 
not known .
• The most common route of transmission in our study was vertical transmission 
which was seen in 143 patients (95.3%) and only 6 (4%) patients acquired HIV 
infection through blood transmission. 
• 54% of patients were breast fed while bottle feeding was seen in 8% of patient 
and rest of the patients had combination of both.
• The most common systemic lesion observed in our study was lymphadenopathy 
followed by tuberculosis, pulmonary tuberculosis was seen in 21.3% and extra 
pulmonary tuberculosis was seen in 45.4% of cases. The latter manifested in the 
form of Cold abscess.
• Measles,  otititis  media,  mumps  and parotid  gland enlargement  were  the  other 
systemic infections observed in our study group. Oral pharyngeal candidiais and 
Systemic candidiasis was observed in 4 (2.7%) patients. 
• The  common  skin  lesions  seen  in  our  study were  scabies,  impetigo,  herpetic 
eruption, perioral wart and molluscum contagiosum.
• All the 150 HIV infected children had at least one systemic and oral lesion at the 
time of examination.
• The common oral lesion observed was Oral candidiasis of which PC was the most 
predominant, followed by AC, EC, HC and combination of PC and EC.
• Conventional  gingivitis,  pigmentation,  depapillation  of  tongue,  oral  hairy 
leucoplakia,  oral  ulcer  patients  and  Kaposi’s  sarcoma  were  other  oral  lesions 
observed in our study.
• Samples for candida were collected from 36 asymptomatic and 86 symptomatic 
patients by using swab technique 
• CHROMagar  was  used  to  identify  the  candial  species.  C.albicans  was  the 
common species isolated from both symptomatic and asymptomatic patients. The 
prevelance  of  Candida  species  is  more  in  symptomatic  patients  than  the 
asymptomatic patients which was statistical significant. 
• C.tropicalis, mixed type of colonies of C.albicans with C.krusei and C.tropicalis 
and non-specific species with C.albicans and C.tropicalis were also identified. 
• CFU count was calculated using Samarnayaka technique.  The mean CFU was 
increased  in  symptomatic  than  in  asymptomatic  patients  and  was  statistical 
significant.
In conclusion, all the children in this study presented with at least one oral lesion. 
We state that systemic and oral mucosal lesions are a feature of HIV infection in the 
pediatric  population.  Furthermore,  additional  studies  investigating  the  association 
between  oral  lesion  and CD4 counts  in  a  large  sample  size  would  be  beneficial  for 
developing prognostic markers for HIV infected children in our country. 
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Annexure
Annexure I
1994 Revised classification system for pediatric HIV disease based on 
clinical manifestations
Category N : Not symptomatic
No signs or symptoms as a result of HIV infection or only one of the conditions 
listed in category A
Category A : Mildly symptomatic
Children with two or more of the following conditions but none of the conditions 
listed in Category B or Category 
Lymphadenopathy (>0.5 cm at more than two sites or bilateral at one site)
Hepatomegaly
Splenomegaly
Dermatitis
Parotitis
Recurrent or persistent upper respiratory infection, sinusitis, or otitis media
Category B: Moderately symptomatic
Children  who  have  symptomatic  conditions  ,  other  than  those  listed  in  for 
category A or Category C, that are attributed to HIV infection
Anemia  (8g/dl),  neutropenia  (1000  cella/mm3),  or  thrombocytopenia 
(<100,000cells/mm3) persisting for 30 days or longer
Bacterial  meningitis,  pneumonia,  or  sepsis  (single  episode),  candidiasis, 
oropharyngeal persisting for more than 2 months in children older than 6 months
Cardiomyopathy
Cytomegalovirus infection with onset before age 1 month 
Diarrhea, recurrent or chronic
Hepatitis
Herpes simplex virus (HSV) stomatitis, recurrent (>two episodes within 1 year)
HSV bronchitis, pneumonitis, or esophagitis with onset before the age 1 month
Herpes zoster infection involving at least two distinct periods or more 
Leiomyosarcoma
Lymphoid interstitial pneumonia or pulmonary lymphoid hyperplasia complex
Nephropathy
Nocardiosis
Fever lasting less than 1 month
Toxoplasmosis with onset before age 1 month
Varicella, disseminated
Category C: Severely symptomatic
Children who have any condition listed in the 1987 surveillance case definition 
for AIDS with the exception of LIP
Annexure II
1994 Revised classification system for pediatric HIV disease based on CD4 
cell count and percentage (CDC)
Immune Category <12 momths 1-5 years 6-12 years
CD4 
cells/mm3 
% CD4
cells/mm3     
%   CD4
cells/mm3 
%
Category 1:
No suppression
>1500 25 >1000 >25 >500 >25
Category 2
Moderate 
suppression
750-1499 15-24 500-999 15-24 200-499 15-24
Category 3: 
 Severe suppression
<750 <15 <500 <15 <200 <15
Annexure – III
Classification and diagnostic criteria for oral lesions in HIV infection 
EC Clearinghouse
Group 1: Lesions strongly associated with HIV infection
Candidiasis
Erythematous
Pseudomembranous
Hairy leukoplakia
Kaposi’s sarcoma
Non-Hodgkin’s lymphoma
Periodontal disease
Linear gingival erythema
Necrotising (ulcerative) gingivitis
Necrotising (ulcerative) Periodontitis
Group 2: Lesions less commonly associated with HIV infection
Bacterial infections
Mycobacterium avium-intracellulare
Mycobaterium tuberculosis
Melanotic hyperpigmentation
Necrotising (ulcerative stomatitis
Salivary gland disease
Dry mouth due to decreased salivary flow rate
Unilateral or bilateral swelling of major salaivary glands
Thrombocytopenic purpura
Ulceration NOS (not otherwise specified)
Viral infections
Herpes simplex virus
Human papillomavirus (warty-like lesions)
Condyloma accuminatum
Focal epithelial hyperplasia
Verruca vulgaris
Varicella-zoster virus
Herpes zoster
Varicella
Group 3: Lesions seen in HIV infection
Bacterial infections
Actinomyces israelii
Escherichia coli
Klebsiella pneumoniae
Cat-scratch disease
Drug reactions (ulcerative, erythema multiforme, lichenoid, toxic epidermolysis)
Epithelioid (bacillary) angiomatosis
Fungal infection other than candidiasis
Cryptococcus neoformans
Geotrichum candidum
Histoplasma capsulatum
Mucoraceae (mucormycosis / zygomycosis)
Aspergillus flaws
Neurologic disturbamces
Facial palsy
Trigeminal neuralgia
Recurrent aphthous stomatitis
Viral infections
Cytomegalovirus
Mollucum contagiosum
Annexure IV
Classification of Orofacial Lesions Associated with Pediatric HIV 
infection patients using the framework of the EC-Clearinghouse and 
WHO (1994)
Group 1: Lesions commonly associated with paediatric HIV infection.
Candidiasis
Erythematous
Pseudomembraneous
Angular cheilitis
Herpes simplex virus infection
Linear gingival erythema
Parotid enlargement
Recurrent aphthous ulcers
Minor
Major
Herpetiform
Group 2: Lesions less commonly associated with paediatric HIV infection.
Bacterial infections of oral tissues
Periodontal diseases
Necrotizing (ulcerative) gingivitis
Necrotizing (ulcerative) periodontitis
Necrotizing (ulcerative) stomatitis
Seborrheic dermatitis
Viral infections
Cytomegalovirus
Human papollomavirus
Molluscum contagiosum
Varicella-zoster virus
Herpes-zoster
Varicella
Xerostomia
Group 3: Lesions strongly associated with HIV infection but rate in children.
Neoplasms
Kaposi’s sarcoma and non-Hodgkin’s lymphoma
Oral hairy leukoplakia
Tuberculosis-related ulcers
